Prediction workspace
Duquesne Stanley Druckenmiller
Current-position sell-side warning list, trust-gate context, company change signals, and driver targets. This page keeps model risk work separate from the portfolio dashboard.
Latest warning model
Trim / Exit Risk Warnings
51 / 6541 exit · 10 trim · 2026-03-31 to 2026-06-30
65%Recall 68% · 2,071 historical rows
68%36% historical coverage · High-confidence Trim/Exit only
v1.1 hybrid 2 / Baseline 63Trim 10 / Exit 41 current warnings
2 vs baseline32 vs v1.1 hybrid · 63 model switches
+3.1 pts+1.5 pts vs v1.1 hybrid · calibrated 38%
| Name | Warning | Risk evidence | Selected model | Segment evidence | Model agreement | Context | Company |
|---|---|---|---|---|---|---|---|
| STUBStubhub Holdings Inc.0.25% weight · latest REDUCE | EXIT 63%Exit warning | Trim/Exit 90%calibrated 41% · 31%-51%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | size macro: small: strong tailwind516 rows · 44% hit rate+3.3 pts vs fallback | Baseline risk 90%Hybrid risk 97%v1.2 risk 93% | Industrials and aerospaceDe-riskingrisk onmacro 0.96 | neutralhighmedium |
| MELIMercadoLibre Inc0.14% weight · latest REDUCE | EXIT 52%Exit warning | Trim/Exit 90%calibrated 50% · 38%-62%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | driver liquidity: growth risk-on: easy472 rows · 39% hit rate+3.6 pts vs fallback | Baseline risk 90%Hybrid risk 96%v1.2 risk 90% | Consumer internet and mediaDe-riskingrisk onmacro 1.69 | negativemediummedium |
| DAKTDaktronics Inc0.33% weight · latest REDUCE | REDUCE 53%Trim warning | Trim/Exit 90%calibrated 37% · 30%-44%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | driver liquidity: growth risk-on: easy472 rows · 39% hit rate+3.6 pts vs fallback | Baseline risk 90%Hybrid risk 59%v1.2 risk 47% | Software and AI infrastructureDe-riskingrisk onmacro 1.12 | neutralmediummedium |
| UALUnited Airlines Holdings Inc0.72% weight · latest REDUCE | EXIT 74%Exit warning | Trim/Exit 89%calibrated 52% · 49%-55%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | driver liquidity: growth risk-on: easy472 rows · 39% hit rate+3.6 pts vs fallback | Baseline risk 89%Hybrid risk 93%v1.2 risk 87% | OtherDe-riskingrisk onmacro 1.77 | positiveneutralmedium |
| WWDWoodward Inc2.24% weight · latest REDUCE | REDUCE 87%Trim warning | Trim/Exit 88%calibrated 45% · 38%-52%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | rules action: reduce249 rows · 43% hit rate+3.6 pts vs fallback | Baseline risk 88%Hybrid risk 95%v1.2 risk 90% | Industrials and aerospaceDe-riskingrisk onmacro 0.96 | neutralmediummedium |
| TSMTaiwan Semiconductor Manufactu4.96% weight · latest REDUCE | REDUCE 84%Trim warning | Trim/Exit 87%calibrated 45% · 38%-52%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | driver liquidity: growth risk-on: easy472 rows · 39% hit rate+3.6 pts vs fallback | Baseline risk 87%Hybrid risk 76%v1.2 risk 68% | SemiconductorsDe-riskingrisk onmacro 1.59 | neutralneutrallow |
| BEBloom Energy Corp0.55% weight · latest REDUCE | EXIT 72%Exit warning | Trim/Exit 86%calibrated 52% · 49%-55%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | size macro: small: strong tailwind516 rows · 44% hit rate+3.3 pts vs fallback | Baseline risk 86%Hybrid risk 51%v1.2 risk 39% | Industrials and aerospaceDe-riskingrisk onmacro 0.96 | positiveneutralmedium |
| AMZNAmazon.com Inc0.28% weight · latest REDUCE | EXIT 64%Exit warning | Trim/Exit 86%calibrated 41% · 31%-51%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | driver liquidity: growth risk-on: easy472 rows · 39% hit rate+3.6 pts vs fallback | Baseline risk 86%Hybrid risk 67%v1.2 risk 56% | Consumer internet and mediaDe-riskingrisk onmacro 1.69 | positiveneutralmedium |
| FIGRFigure Technology Solutions In1.16% weight · latest REDUCE | REDUCE 63%Trim warning | Trim/Exit 85%calibrated 39% · 28%-50%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | rules action: reduce249 rows · 43% hit rate+3.6 pts vs fallback | Baseline risk 85%Hybrid risk 91%v1.2 risk 87% | OtherDe-riskingrisk onmacro 0.98 | positiveneutralmedium |
| PCTPureCycle Technologies Inc.0.15% weight · latest REDUCE | EXIT 66%Exit warning | Trim/Exit 84%calibrated 41% · 31%-51%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | size macro: small: strong tailwind516 rows · 44% hit rate+3.3 pts vs fallback | Baseline risk 84%Hybrid risk 59%v1.2 risk 47% | Energy and materialsDe-riskingrisk onmacro 2.40 | negativehighmedium |
| INSMInsmed Inc5.59% weight · latest REDUCE | REDUCE 80%Trim warning | Trim/Exit 81%calibrated 45% · 38%-52%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | rules action: reduce249 rows · 43% hit rate+3.6 pts vs fallback | Baseline risk 81%Hybrid risk 86%v1.2 risk 82% | Healthcare and biotechDe-riskingrisk onmacro 0.90 | neutralmediummedium |
| TEVATeva Pharmaceutical Industries2.12% weight · latest REDUCE | REDUCE 76%Trim warning | Trim/Exit 80%calibrated 45% · 38%-52%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | v11 action: add418 rows · 29% hit rate+3.1 pts vs fallback | Baseline risk 80%Hybrid risk 34%v1.2 risk 21% | Healthcare and biotechDe-riskingrisk onmacro 0.90 | neutralmediummedium |
| LSCCLattice Semiconductor Corp.0.89% weight · latest REDUCE | EXIT 54%Exit warning | Trim/Exit 80%calibrated 50% · 38%-62%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | driver liquidity: growth risk-on: easy472 rows · 39% hit rate+3.6 pts vs fallback | Baseline risk 80%Hybrid risk 93%v1.2 risk 90% | SemiconductorsDe-riskingrisk onmacro 1.12 | positiveneutralmedium |
| EWZiShares MSCI Brazil ETF3.91% weight · latest HOLD | EXIT 39%Exit warning | Trim/Exit 78%calibrated 24% · 12%-36%Differs from baseline risk read | v1.1 hybrid 75/25fallback v1.1 hybrid | global2,071 rows · 41% hit rate0.0 pts vs fallback | Baseline risk 26%Hybrid risk 78%v1.2 risk 90% | OtherDe-riskingrisk onmacro 0.31 | neutralneutralunknown |
| CRHCRH Plc1.18% weight · latest REDUCE | REDUCE 49%Trim warning | Trim/Exit 77%calibrated 30% · 22%-38%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | rules action: reduce249 rows · 43% hit rate+3.6 pts vs fallback | Baseline risk 77%Hybrid risk 87%v1.2 risk 82% | Energy and materialsDe-riskingrisk onmacro 2.40 | negativehighmedium |
| DBVTDBV Technologies0.24% weight · latest ADD | EXIT 72%Exit warning | Trim/Exit 77%calibrated 52% · 49%-55%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | size macro: small: strong tailwind516 rows · 44% hit rate+3.3 pts vs fallback | Baseline risk 77%Hybrid risk 20%v1.2 risk 4% | Healthcare and biotechDe-riskingrisk onmacro 0.90 | negativehighmedium |
| JBSJBS N.V.0.35% weight · latest ADD | EXIT 72%Exit warning | Trim/Exit 76%calibrated 52% · 49%-55%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | driver liquidity: growth risk-on: easy472 rows · 39% hit rate+3.6 pts vs fallback | Baseline risk 76%Hybrid risk 22%v1.2 risk 5% | Consumer internet and mediaDe-riskingrisk onmacro 1.49 | neutralneutralunknown |
| VISTVista Energy S.A.B. de C.V0.30% weight · latest ADD | EXIT 72%Exit warning | Trim/Exit 76%calibrated 52% · 49%-55%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | size macro: small: strong tailwind516 rows · 44% hit rate+3.3 pts vs fallback | Baseline risk 76%Hybrid risk 21%v1.2 risk 2% | Energy and materialsDe-riskingrisk onmacro 2.98 | neutralneutrallow |
| TWSTTwist Bioscience Corp0.29% weight · latest ADD | EXIT 72%Exit warning | Trim/Exit 76%calibrated 52% · 49%-55%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | size macro: small: strong tailwind516 rows · 44% hit rate+3.3 pts vs fallback | Baseline risk 76%Hybrid risk 57%v1.2 risk 48% | Healthcare and biotechDe-riskingrisk onmacro 0.90 | neutralneutralmedium |
| CLSCelestica Inc0.28% weight · latest ADD | EXIT 72%Exit warning | Trim/Exit 76%calibrated 52% · 49%-55%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | driver liquidity: growth risk-on: easy472 rows · 39% hit rate+3.6 pts vs fallback | Baseline risk 76%Hybrid risk 24%v1.2 risk 8% | Software and AI infrastructureDe-riskingrisk onmacro 1.12 | positiveneutralmedium |
| LITELumentum Holdings Inc0.14% weight · latest ADD | EXIT 72%Exit warning | Trim/Exit 76%calibrated 52% · 49%-55%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | driver liquidity: growth risk-on: easy472 rows · 39% hit rate+3.6 pts vs fallback | Baseline risk 76%Hybrid risk 73%v1.2 risk 68% | SemiconductorsDe-riskingrisk onmacro 1.12 | positiveneutralmedium |
| SOLSSolstice Advanced Materials In0.14% weight · latest ADD | EXIT 72%Exit warning | Trim/Exit 76%calibrated 52% · 49%-55%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | size macro: small: strong tailwind516 rows · 44% hit rate+3.3 pts vs fallback | Baseline risk 76%Hybrid risk 56%v1.2 risk 45% | Energy and materialsDe-riskingrisk onmacro 2.40 | positiveneutralmedium |
| WLKWestlake Corporation0.07% weight · latest ADD | EXIT 72%Exit warning | Trim/Exit 75%calibrated 52% · 49%-55%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | size macro: small: strong tailwind516 rows · 44% hit rate+3.3 pts vs fallback | Baseline risk 75%Hybrid risk 43%v1.2 risk 29% | Energy and materialsDe-riskingrisk onmacro 2.40 | negativehighmedium |
| WABWestinghouse Air Brake Technol0.70% weight · latest REDUCE | EXIT 42%Exit warning | Trim/Exit 72%calibrated 30% · 22%-38%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | size macro: small: strong tailwind516 rows · 44% hit rate+3.3 pts vs fallback | Baseline risk 72%Hybrid risk 24%v1.2 risk 10% | Industrials and aerospaceDe-riskingrisk onmacro 0.96 | positiveneutralmedium |
| OLMAOlema Pharmaceuticals Inc0.44% weight · latest ADD | EXIT 66%Exit warning | Trim/Exit 72%calibrated 41% · 31%-51%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | size macro: small: strong tailwind516 rows · 44% hit rate+3.3 pts vs fallback | Baseline risk 72%Hybrid risk 39%v1.2 risk 29% | Healthcare and biotechDe-riskingrisk onmacro 0.90 | negativehighmedium |
| NUVBNuvation Bio Inc0.58% weight · latest ADD | EXIT 66%Exit warning | Trim/Exit 71%calibrated 41% · 31%-51%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | size macro: small: strong tailwind516 rows · 44% hit rate+3.3 pts vs fallback | Baseline risk 71%Hybrid risk 89%v1.2 risk 88% | Healthcare and biotechDe-riskingrisk onmacro 0.90 | neutralmediummedium |
| HUMHumana Inc0.71% weight · latest ADD | EXIT 67%Exit warning | Trim/Exit 70%calibrated 41% · 31%-51%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | size macro: small: strong tailwind516 rows · 44% hit rate+3.3 pts vs fallback | Baseline risk 70%Hybrid risk 86%v1.2 risk 85% | Healthcare and biotechDe-riskingrisk onmacro 0.90 | positiveneutralmedium |
| AAAlcoa Corp2.93% weight · latest ADD | REDUCE 68%Trim warning | Trim/Exit 69%calibrated 39% · 28%-50%Differs from baseline risk read | v1.1 hybrid 75/25fallback v1.1 hybrid | global2,071 rows · 41% hit rate0.0 pts vs fallback | Baseline risk 15%Hybrid risk 69%v1.2 risk 79% | Energy and materialsDe-riskingrisk onmacro 2.40 | negativemediummedium |
| XENEXenon Pharmaceuticals Inc0.41% weight · latest ADD | EXIT 61%Exit warning | Trim/Exit 67%calibrated 41% · 31%-51%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | size macro: small: strong tailwind516 rows · 44% hit rate+3.3 pts vs fallback | Baseline risk 67%Hybrid risk 17%v1.2 risk 3% | Healthcare and biotechDe-riskingrisk onmacro 0.90 | negativehighmedium |
| QSRRestaurant Brands Internationa0.99% weight · latest REDUCE | REDUCE 35%Trim warning | Trim/Exit 67%calibrated 24% · 12%-36%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | driver liquidity: growth risk-on: easy472 rows · 39% hit rate+3.6 pts vs fallback | Baseline risk 67%Hybrid risk 29%v1.2 risk 16% | Consumer internet and mediaDe-riskingrisk onmacro 1.69 | positiveneutralmedium |
| GSGiShares S&P GSCI Commodity-Ind0.61% weight · latest ADD | EXIT 61%Exit warning | Trim/Exit 67%calibrated 41% · 31%-51%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | rules action: exit840 rows · 53% hit rate+7.4 pts vs fallback | Baseline risk 67%Hybrid risk 91%v1.2 risk 93% | OtherDe-riskingrisk onmacro 0.31 | neutralneutrallow |
| BLTEBelite Bio Inc0.50% weight · latest ADD | EXIT 61%Exit warning | Trim/Exit 67%calibrated 41% · 31%-51%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | size macro: small: strong tailwind516 rows · 44% hit rate+3.3 pts vs fallback | Baseline risk 67%Hybrid risk 80%v1.2 risk 79% | Healthcare and biotechDe-riskingrisk onmacro 0.90 | neutralneutrallow |
| JBLJabil Inc0.65% weight · latest ADD | EXIT 61%Exit warning | Trim/Exit 67%calibrated 41% · 31%-51%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | driver liquidity: growth risk-on: easy472 rows · 39% hit rate+3.6 pts vs fallback | Baseline risk 67%Hybrid risk 29%v1.2 risk 17% | Software and AI infrastructureDe-riskingrisk onmacro 1.12 | positiveneutralmedium |
| QQnity Electronics Inc0.43% weight · latest ADD | EXIT 61%Exit warning | Trim/Exit 67%calibrated 41% · 31%-51%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | driver liquidity: growth risk-on: easy472 rows · 39% hit rate+3.6 pts vs fallback | Baseline risk 67%Hybrid risk 91%v1.2 risk 91% | SemiconductorsDe-riskingrisk onmacro 1.12 | positiveneutralmedium |
| COHRCoherent Corp0.28% weight · latest ADD | EXIT 62%Exit warning | Trim/Exit 66%calibrated 41% · 31%-51%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | driver liquidity: growth risk-on: easy472 rows · 39% hit rate+3.6 pts vs fallback | Baseline risk 66%Hybrid risk 87%v1.2 risk 86% | SemiconductorsDe-riskingrisk onmacro 1.77 | positiveneutralmedium |
| WVEWAVE Life Sciences Ltd0.04% weight · latest HOLD | EXIT 60%Exit warning | Trim/Exit 64%calibrated 41% · 31%-51%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | size macro: small: strong tailwind516 rows · 44% hit rate+3.3 pts vs fallback | Baseline risk 64%Hybrid risk 90%v1.2 risk 92% | Healthcare and biotechDe-riskingrisk onmacro 0.90 | positiveneutralmedium |
| ADMAADMA Biologics Inc0.41% weight · latest ADD | EXIT 57%Exit warning | Trim/Exit 61%calibrated 50% · 38%-62%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | size macro: small: strong tailwind516 rows · 44% hit rate+3.3 pts vs fallback | Baseline risk 61%Hybrid risk 90%v1.2 risk 93% | Healthcare and biotechDe-riskingrisk onmacro 0.90 | neutralhighmedium |
| ALMAlmonty Industries Inc0.20% weight · latest HOLD | EXIT 51%Exit warning | Trim/Exit 61%calibrated 50% · 38%-62%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | size macro: small: strong tailwind516 rows · 44% hit rate+3.3 pts vs fallback | Baseline risk 61%Hybrid risk 16%v1.2 risk 2% | Energy and materialsDe-riskingrisk onmacro 2.40 | neutralneutrallow |
| NETCloudflare Inc0.32% weight · latest ADD | EXIT 55%Exit warning | Trim/Exit 59%calibrated 50% · 38%-62%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | driver liquidity: growth risk-on: easy472 rows · 39% hit rate+3.6 pts vs fallback | Baseline risk 59%Hybrid risk 55%v1.2 risk 51% | Software and AI infrastructureDe-riskingrisk onmacro 1.12 | negativehighmedium |
| LYBLyondellBasell Industries NV0.31% weight · latest ADD | EXIT 55%Exit warning | Trim/Exit 59%calibrated 50% · 38%-62%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | size macro: small: strong tailwind516 rows · 44% hit rate+3.3 pts vs fallback | Baseline risk 59%Hybrid risk 52%v1.2 risk 46% | Energy and materialsDe-riskingrisk onmacro 2.40 | negativemediummedium |
| MUMicron Technology Inc0.23% weight · latest ADD | EXIT 54%Exit warning | Trim/Exit 58%calibrated 50% · 38%-62%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | driver liquidity: growth risk-on: easy472 rows · 39% hit rate+3.6 pts vs fallback | Baseline risk 58%Hybrid risk 89%v1.2 risk 92% | SemiconductorsDe-riskingrisk onmacro 1.12 | positiveneutralmedium |
| STXSeagate Technology Holdings Pl0.59% weight · latest ADD | EXIT 49%Exit warning | Trim/Exit 55%calibrated 30% · 22%-38%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | driver liquidity: growth risk-on: easy472 rows · 39% hit rate+3.6 pts vs fallback | Baseline risk 55%Hybrid risk 33%v1.2 risk 26% | Software and AI infrastructureDe-riskingrisk onmacro 1.12 | positiveneutralmedium |
| ARMArm Holdings plc0.48% weight · latest ADD | EXIT 49%Exit warning | Trim/Exit 54%calibrated 30% · 22%-38%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | driver liquidity: growth risk-on: easy472 rows · 39% hit rate+3.6 pts vs fallback | Baseline risk 54%Hybrid risk 89%v1.2 risk 92% | SemiconductorsDe-riskingrisk onmacro 1.12 | neutralneutrallow |
| SCCOSouthern Copper Corporation0.62% weight · latest HOLD | EXIT 42%Exit warning | Trim/Exit 51%calibrated 30% · 22%-38%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | size macro: small: strong tailwind516 rows · 44% hit rate+3.3 pts vs fallback | Baseline risk 51%Hybrid risk 30%v1.2 risk 21% | Energy and materialsDe-riskingrisk onmacro 2.40 | positiveneutralmedium |
| RVMDRevolution Medicines Inc0.91% weight · latest ADD | EXIT 39%Exit warning | Trim/Exit 49%calibrated 24% · 12%-36%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | size macro: small: strong tailwind516 rows · 44% hit rate+3.3 pts vs fallback | Baseline risk 49%Hybrid risk 34%v1.2 risk 29% | Healthcare and biotechDe-riskingrisk onmacro 0.90 | negativehighlow |
| NTRANatera Inc18.14% weight · latest ADD | REDUCE 48%Trim warning | Trim/Exit 48%calibrated 30% · 22%-38%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | v11 action: hold409 rows · 45% hit rate+9.3 pts vs fallback | Baseline risk 48%Hybrid risk 35%v1.2 risk 32% | Healthcare and biotechDe-riskingrisk onmacro 0.90 | negativehighmedium |
| CAICaris Life Sciences Inc.1.00% weight · latest ADD | EXIT 36%Exit warning | Trim/Exit 48%calibrated 24% · 12%-36%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | v11 action: add418 rows · 29% hit rate+3.1 pts vs fallback | Baseline risk 48%Hybrid risk 37%v1.2 risk 33% | Healthcare and biotechDe-riskingrisk onmacro 0.90 | positiveneutralmedium |
| INTCIntel Corp0.54% weight · latest ADD | EXIT 43%Exit warning | Trim/Exit 48%calibrated 30% · 22%-38%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | driver liquidity: growth risk-on: easy472 rows · 39% hit rate+3.6 pts vs fallback | Baseline risk 48%Hybrid risk 86%v1.2 risk 92% | SemiconductorsDe-riskingrisk onmacro 1.12 | negativehighmedium |
| LINLinde Plc0.60% weight · latest ADD | EXIT 42%Exit warning | Trim/Exit 47%calibrated 30% · 22%-38%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | size macro: small: strong tailwind516 rows · 44% hit rate+3.3 pts vs fallback | Baseline risk 47%Hybrid risk 48%v1.2 risk 44% | Energy and materialsDe-riskingrisk onmacro 2.40 | neutralneutralmedium |
| SNDKSandisk Corp0.72% weight · latest ADD | EXIT 42%Exit warning | Trim/Exit 47%calibrated 30% · 22%-38%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | driver liquidity: growth risk-on: easy472 rows · 39% hit rate+3.6 pts vs fallback | Baseline risk 47%Hybrid risk 49%v1.2 risk 47% | Software and AI infrastructureDe-riskingrisk onmacro 1.12 | positiveneutralmedium |
| TWLOTwilio Inc0.68% weight · latest ADD | EXIT 42%Exit warning | Trim/Exit 47%calibrated 30% · 22%-38%Agrees with baseline risk read | Baselinefallback v1.1 hybrid | driver liquidity: growth risk-on: easy472 rows · 39% hit rate+3.6 pts vs fallback | Baseline risk 47%Hybrid risk 70%v1.2 risk 73% | Software and AI infrastructureDe-riskingrisk onmacro 1.12 | positiveneutralmedium |
| Highest risk warnings | Router warning | Selected model | Risk probability stack | Lifecycle |
|---|---|---|---|---|
| STUBStubhub Holdings Inc.0.25% weight | EXIT 63%calibrated 41% · low | Baselinesize macro: small: strong tailwind | Trim/Exit 90%Reduce 27%Exit 63% | developingsmallreducing_streak |
| MELIMercadoLibre Inc0.14% weight | EXIT 52%calibrated 50% · low | Baselinedriver liquidity: growth risk-on: easy | Trim/Exit 90%Reduce 38%Exit 52% | reentrysmallreducing_streak |
| DAKTDaktronics Inc0.33% weight | REDUCE 53%calibrated 37% · medium | Baselinedriver liquidity: growth risk-on: easy | Trim/Exit 90%Reduce 53%Exit 37% | maturesmallreducing_streak |
| UALUnited Airlines Holdings Inc0.72% weight | EXIT 74%calibrated 52% · high | Baselinedriver liquidity: growth risk-on: easy | Trim/Exit 89%Reduce 14%Exit 74% | reentrysmalllatest_reduce |
| WWDWoodward Inc2.24% weight | REDUCE 87%calibrated 45% · medium | Baselinerules action: reduce | Trim/Exit 88%Reduce 87%Exit 1% | maturemediumreducing_streak |
| TSMTaiwan Semiconductor Manufactu4.96% weight | REDUCE 84%calibrated 45% · medium | Baselinedriver liquidity: growth risk-on: easy | Trim/Exit 87%Reduce 84%Exit 3% | reentrycorereducing_streak |
| BEBloom Energy Corp0.55% weight | EXIT 72%calibrated 52% · high | Baselinesize macro: small: strong tailwind | Trim/Exit 86%Reduce 14%Exit 72% | newsmalllatest_reduce |
| AMZNAmazon.com Inc0.28% weight | EXIT 64%calibrated 41% · low | Baselinedriver liquidity: growth risk-on: easy | Trim/Exit 86%Reduce 22%Exit 64% | reentrysmalllatest_reduce |
| FIGRFigure Technology Solutions In1.16% weight | REDUCE 63%calibrated 39% · low | Baselinerules action: reduce | Trim/Exit 85%Reduce 63%Exit 22% | developingmediumreducing_streak |
| PCTPureCycle Technologies Inc.0.15% weight | EXIT 66%calibrated 41% · low | Baselinesize macro: small: strong tailwind | Trim/Exit 84%Reduce 18%Exit 66% | developingsmalllatest_reduce |
| INSMInsmed Inc5.59% weight | REDUCE 80%calibrated 45% · medium | Baselinerules action: reduce | Trim/Exit 81%Reduce 80%Exit 1% | reentrycorereducing_streak |
| TEVATeva Pharmaceutical Industries2.12% weight | REDUCE 76%calibrated 45% · medium | Baselinev11 action: add | Trim/Exit 80%Reduce 76%Exit 3% | reentrymediumreducing_streak |
This page now shows sell-side warnings only. Non-sell-side predictions are kept out of the current action list because the backtest is strongest for the reduce/exit direction. Visible current warnings are driven by the latest production router plus trust-gate context. Baseline checks are kept internal as supporting evidence only.
Company signals
Company Change Signals
65One local signal per current common holding
623 need manual or macro-source review
23Prioritized for sell-side risk review
350SEC, FMP, Alpha Vantage, and local price facts
62Signals with medium or high evidence quality
| Name | Overall | Earnings | KPI | Co. guidance | Expectations | Tone | Valuation | Risk | Quality | Summary | Factors | Evidence | Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NTRANatera Inc18.14% weight | negative | negative | negative | neutral | positive | positive | high | high | high79 | Latest SEC periodic filing is 10-Q filed 2026-05-08 for period 2026-03-31. Fundamental signals need caution based on available SEC XBRL facts. | SEC XBRL revenue $696.6M for 2026-03-31, +38.8% vs comparison period. | 5 sourcesSEC · Latest filingneutral 10-Q filed 2026-05-08Period 2026-03-31.As of 2026-05-08 SEC · Revenue trendpositive +38.8%Revenue $696.6M for 2026-03-31.As of 2026-03-31 SEC · Operating incomenegative -$93.5M-18.1% versus comparison period.As of 2026-03-31 SEC · Net incomenegative -$85.1M-27.1% versus comparison period.As of 2026-03-31 Local price · YTD returnneutral -11.1%Latest local close 203.69 on 2026-05-21.As of 2026-05-21 | auto collected2026-05-23 |
| INSMInsmed Inc5.59% weight | neutral | positive | positive | neutral | negative | positive | medium | high | high83 | Latest SEC periodic filing is 10-Q filed 2026-05-07 for period 2026-03-31. Fundamental signals need caution based on available SEC XBRL facts. | SEC XBRL revenue $306.0M for 2026-03-31, +229.6% vs comparison period.Operating income loss narrowed to -$153.3M for 2026-03-31, +38.2% improvement vs comparison period.Net income loss narrowed to -$163.6M for 2026-03-31, +36.3% improvement vs comparison period. | 6 sourcesSEC · Latest filingneutral 10-Q filed 2026-05-07Period 2026-03-31.As of 2026-05-07 SEC · Revenue trendpositive +229.6%Revenue $306.0M for 2026-03-31.As of 2026-03-31 SEC · Operating incomeneutral -$153.3M+38.2% versus comparison period.As of 2026-03-31 SEC · Net incomeneutral -$163.6M+36.3% versus comparison period.As of 2026-03-31 SEC · Cashpositive $582.2MLatest usable SEC cash fact.As of 2026-03-31 | auto collected2026-05-23 |
| TSMTaiwan Semiconductor Manufactu4.96% weight | positive | positive | neutral | neutral | positive | positive | medium | neutral | medium58 | Latest SEC periodic filing is 20-F filed 2026-04-16 for period 2025-12-31. Available SEC XBRL facts are neutral or incomplete for the watched KPI template. | Confirm that AI/HPC demand and leading-edge utilization offset cyclicality and geopolitical risk. | 2 sourcesSEC · Latest filingneutral 20-F filed 2026-04-16Period 2025-12-31.As of 2026-04-16 Local price · YTD returnneutral +34.0%Latest local close 407.15 on 2026-05-21.As of 2026-05-21 | auto collected2026-05-23 |
| YPFYPF S.A. ADR4.43% weight | neutral | positive | neutral | neutral | neutral | positive | medium | neutral | medium58 | Latest SEC periodic filing is 20-F filed 2026-03-26 for period 2025-12-31. Available SEC XBRL facts are neutral or incomplete for the watched KPI template. | Confirm that cash flow and capital allocation stay strong across the commodity cycle. | 2 sourcesSEC · Latest filingneutral 20-F filed 2026-03-26Period 2025-12-31.As of 2026-03-26 Local price · YTD returnneutral +32.6%Latest local close 47.94 on 2026-05-21.As of 2026-05-21 | auto collected2026-05-23 |
| EWZiShares MSCI Brazil ETF3.91% weight | neutral | neutral | neutral | Not applicable | Not applicable | Not applicable | Not applicable | neutral | low20 | This looks like an ETF, trust, index product, or macro exposure. Use underlying exposure, flows, country/commodity data, and liquidity rather than company financial statements. | Local price snapshot shows +16.5% YTD return. | 1 sourcesLocal price · YTD returnneutral +16.5%Non-operating security uses macro/market evidence until underlying exposure data is added.As of 2026-05-21 | needs review2026-05-23 |
| TBBBBBB Foods Inc3.26% weight | negative | negative | neutral | neutral | positive | positive | high | medium | medium58 | Latest SEC periodic filing is 20-F filed 2026-04-02 for period 2025-12-31. Available SEC XBRL facts are neutral or incomplete for the watched KPI template. | Confirm that demand and margins improve without excessive valuation pressure. | 2 sourcesSEC · Latest filingneutral 20-F filed 2026-04-02Period 2025-12-31.As of 2026-04-02 Local price · YTD returnneutral +11.4%Latest local close 37.2 on 2026-05-21.As of 2026-05-21 | auto collected2026-05-23 |
| AAAlcoa Corp2.93% weight | neutral | positive | negative | neutral | positive | positive | medium | medium | high79 | Latest SEC periodic filing is 10-Q filed 2026-04-30 for period 2026-03-31. Fundamental signals need caution based on available SEC XBRL facts. | Latest SEC cash fact is $1.35B as of 2026-03-31. | 5 sourcesSEC · Latest filingneutral 10-Q filed 2026-04-30Period 2026-03-31.As of 2026-04-30 SEC · Revenue trendnegative -5.2%Revenue $3.19B for 2026-03-31.As of 2026-03-31 SEC · Net incomeneutral $425.0M-22.4% versus comparison period.As of 2026-03-31 SEC · Cashpositive $1.35BLatest usable SEC cash fact.As of 2026-03-31 Local price · YTD returnneutral +24.7%Latest local close 66.27 on 2026-05-21.As of 2026-05-21 | auto collected2026-05-23 |
| NAMSNewAmsterdam Pharma Company NV2.91% weight | negative | positive | negative | No explicit guide | positive | positive | high | high | high83 | Latest SEC periodic filing is 10-Q filed 2026-05-07 for period 2026-03-31. Fundamental signals need caution based on available SEC XBRL facts. | Latest SEC cash fact is $457.6M as of 2026-03-31. | 6 sourcesSEC · Latest filingneutral 10-Q filed 2026-05-07Period 2026-03-31.As of 2026-05-07 SEC · Revenue trendneutral +2.1%Revenue $3.0M for 2026-03-31.As of 2026-03-31 SEC · Operating incomeneutral -$58.4M+15.2% versus comparison period.As of 2026-03-31 SEC · Net incomenegative -$48.4M-22.6% versus comparison period.As of 2026-03-31 SEC · Cashpositive $457.6MLatest usable SEC cash fact.As of 2026-03-31 | auto collected2026-05-23 |
| SESea Ltd2.70% weight | positive | positive | neutral | neutral | positive | positive | low | low | medium65 | Latest SEC periodic filing is 20-F filed 2026-04-17 for period 2025-12-31. Fundamental signals need caution based on available SEC XBRL facts. | Latest SEC cash fact is $4.16B as of 2025-12-31. | 3 sourcesSEC · Latest filingneutral 20-F filed 2026-04-17Period 2025-12-31.As of 2026-04-17 SEC · Cashpositive $4.16BLatest usable SEC cash fact.As of 2025-12-31 Local price · YTD returnnegative -30.3%Latest local close 88.96 on 2026-05-21.As of 2026-05-21 | auto collected2026-05-23 |
| STMSTMicroelectronics N.V. ADS AD2.67% weight | negative | negative | neutral | neutral | positive | positive | high | medium | medium65 | Latest SEC periodic filing is 20-F filed 2026-02-26 for period 2025-12-31. Fundamental signals skew positive based on available SEC XBRL facts. | Local price snapshot shows +153.1% YTD return, confirming market momentum but adding valuation pressure.Latest SEC cash fact is $2.84B as of 2025-12-31. | 3 sourcesSEC · Latest filingneutral 20-F filed 2026-02-26Period 2025-12-31.As of 2026-02-26 SEC · Cashpositive $2.84BLatest usable SEC cash fact.As of 2025-12-31 Local price · YTD returnpositive +153.1%Latest local close 65.66 on 2026-05-21.As of 2026-05-21 | auto collected2026-05-23 |
| WWDWoodward Inc2.24% weight | positive | positive | positive | positive | positive | positive | medium | low | high99 | Latest SEC periodic filing is 10-Q filed 2026-04-30 for period 2026-03-31. Fundamental signals skew positive based on available SEC XBRL facts. | SEC XBRL revenue $1.09B for 2026-03-31, +23.4% vs comparison period.Net income $134.0M for 2026-03-31, +23.0% vs comparison period.Latest SEC cash fact is $501.2M as of 2026-03-31. | 5 sourcesSEC · Latest filingneutral 10-Q filed 2026-04-30Period 2026-03-31.As of 2026-04-30 SEC · Revenue trendpositive +23.4%Revenue $1.09B for 2026-03-31.As of 2026-03-31 SEC · Net incomepositive $134.0M+23.0% versus comparison period.As of 2026-03-31 SEC · Cashpositive $501.2MLatest usable SEC cash fact.As of 2026-03-31 Local price · YTD returnneutral +17.7%Latest local close 355.76 on 2026-05-21.As of 2026-05-21 | auto collected2026-05-23 |
| TEVATeva Pharmaceutical Industries2.12% weight | positive | positive | positive | neutral | positive | positive | medium | low | high83 | Latest SEC periodic filing is 10-Q filed 2026-04-29 for period 2026-03-31. Fundamental signals skew positive based on available SEC XBRL facts. | Operating income $652.0M for 2026-03-31, +25.6% vs comparison period.Net income $369.0M for 2026-03-31, +72.4% vs comparison period.Latest SEC cash fact is $3.74B as of 2026-03-31. | 7 sourcesSEC · Latest filingneutral 10-Q filed 2026-04-29Period 2026-03-31.As of 2026-04-29 SEC · Revenue trendneutral +2.3%Revenue $3.98B for 2026-03-31.As of 2026-03-31 SEC · Gross marginneutral +49.5%Margin change +1.3% points versus comparison period.As of 2026-03-31 SEC · Operating incomepositive $652.0M+25.6% versus comparison period.As of 2026-03-31 SEC · Net incomepositive $369.0M+72.4% versus comparison period.As of 2026-03-31 | auto collected2026-05-23 |
| ROKURoku Inc2.10% weight | neutral | positive | positive | neutral | positive | positive | high | medium | high83 | Latest SEC periodic filing is 10-Q filed 2026-05-01 for period 2026-03-31. Fundamental signals skew positive based on available SEC XBRL facts. | SEC XBRL revenue $1.25B for 2026-03-31, +22.4% vs comparison period.Operating income $51.8M for 2026-03-31, +189.7% vs comparison period.Net income $85.7M for 2026-03-31, +412.4% vs comparison period. | 7 sourcesSEC · Latest filingneutral 10-Q filed 2026-05-01Period 2026-03-31.As of 2026-05-01 SEC · Revenue trendpositive +22.4%Revenue $1.25B for 2026-03-31.As of 2026-03-31 SEC · Gross marginneutral +45.2%Margin change +1.6% points versus comparison period.As of 2026-03-31 SEC · Operating incomepositive $51.8M+189.7% versus comparison period.As of 2026-03-31 SEC · Net incomepositive $85.7M+412.4% versus comparison period.As of 2026-03-31 | auto collected2026-05-23 |
| AVGOBroadcom Inc1.80% weight | negative | negative | neutral | neutral | positive | positive | high | high | high83 | Latest SEC periodic filing is 10-Q filed 2026-03-11 for period 2026-02-01. Fundamental signals need caution based on available SEC XBRL facts. | SEC XBRL revenue $19.31B for 2026-02-01, +29.5% vs comparison period.Operating income $8.56B for 2026-02-01, +36.8% vs comparison period.Latest SEC cash fact is $14.17B as of 2026-02-01. | 7 sourcesSEC · Latest filingneutral 10-Q filed 2026-03-11Period 2026-02-01.As of 2026-03-11 SEC · Revenue trendpositive +29.5%Revenue $19.31B for 2026-02-01.As of 2026-02-01 SEC · Gross marginneutral +68.1%Margin change +0.1% points versus comparison period.As of 2026-02-01 SEC · Operating incomepositive $8.56B+36.8% versus comparison period.As of 2026-02-01 SEC · Net incomeneutral $715.0M-40.2% versus comparison period.As of 2019-08-04 | auto collected2026-05-23 |
| CPNGCoupang Inc1.49% weight | negative | negative | negative | neutral | positive | positive | low | high | high83 | Latest SEC periodic filing is 10-Q filed 2026-05-05 for period 2026-03-31. Fundamental signals need caution based on available SEC XBRL facts. | Latest SEC cash fact is $6.30B as of 2026-03-31. | 7 sourcesSEC · Latest filingneutral 10-Q filed 2026-05-05Period 2026-03-31.As of 2026-05-05 SEC · Revenue trendneutral +7.5%Revenue $8.50B for 2026-03-31.As of 2026-03-31 SEC · Gross marginnegative +27.0%Margin change -2.3% points versus comparison period.As of 2026-03-31 SEC · Operating incomenegative -$242.0M-257.1% versus comparison period.As of 2026-03-31 SEC · Net incomenegative -$266.0M-348.6% versus comparison period.As of 2026-03-31 | auto collected2026-05-23 |
| OPCHOption Care Health Inc.1.49% weight | positive | positive | positive | neutral | positive | positive | low | low | high83 | Latest SEC periodic filing is 10-Q filed 2026-04-30 for period 2026-03-31. Fundamental signals need caution based on available SEC XBRL facts. | SEC XBRL revenue $1.44B for 2025-09-30, +12.2% vs comparison period.Latest SEC cash fact is $177.3M as of 2026-03-31. | 6 sourcesSEC · Latest filingneutral 10-Q filed 2026-04-30Period 2026-03-31.As of 2026-04-30 SEC · Revenue trendpositive +12.2%Revenue $1.44B for 2025-09-30.As of 2025-09-30 SEC · Operating incomeneutral $72.5M-8.4% versus comparison period.As of 2026-03-31 SEC · Net incomeneutral $45.3M-3.0% versus comparison period.As of 2026-03-31 SEC · Cashpositive $177.3MLatest usable SEC cash fact.As of 2026-03-31 | auto collected2026-05-23 |
| CRHCRH Plc1.18% weight | negative | negative | negative | neutral | negative | positive | medium | high | high83 | Latest SEC periodic filing is 10-Q filed 2026-04-30 for period 2026-03-31. Fundamental signals need caution based on available SEC XBRL facts. | Latest SEC cash fact is $3.24B as of 2026-03-31. | 7 sourcesSEC · Latest filingneutral 10-Q filed 2026-04-30Period 2026-03-31.As of 2026-04-30 SEC · Revenue trendneutral +9.1%Revenue $7.37B for 2026-03-31.As of 2026-03-31 SEC · Gross marginneutral +27.7%Margin change +0.6% points versus comparison period.As of 2026-03-31 SEC · Operating incomenegative -$38.0M-311.1% versus comparison period.As of 2026-03-31 SEC · Net incomenegative -$176.0M-87.2% versus comparison period.As of 2026-03-31 | auto collected2026-05-23 |
| FIGRFigure Technology Solutions In1.16% weight | positive | positive | positive | neutral | positive | positive | medium | low | high83 | Latest SEC periodic filing is 10-Q filed 2026-05-15 for period 2026-03-31. Fundamental signals skew positive based on available SEC XBRL facts. | SEC XBRL revenue $167.0M for 2026-03-31, +97.6% vs comparison period.Operating income $41.9M for 2026-03-31, +419.6% vs comparison period.Net income $44.9M for 2026-03-31, +5581.1% vs comparison period. | 6 sourcesSEC · Latest filingneutral 10-Q filed 2026-05-15Period 2026-03-31.As of 2026-05-15 SEC · Revenue trendpositive +97.6%Revenue $167.0M for 2026-03-31.As of 2026-03-31 SEC · Operating incomepositive $41.9M+419.6% versus comparison period.As of 2026-03-31 SEC · Net incomepositive $44.9M+5581.1% versus comparison period.As of 2026-03-31 SEC · Cashpositive $1.46BLatest usable SEC cash fact.As of 2026-03-31 | auto collected2026-05-23 |
| ARGTGlobal X MSCI Argentina ETF1.07% weight | neutral | neutral | neutral | Not applicable | Not applicable | Not applicable | Not applicable | neutral | low20 | This looks like an ETF, trust, index product, or macro exposure. Use underlying exposure, flows, country/commodity data, and liquidity rather than company financial statements. | Local price snapshot shows +0.7% YTD return. | 1 sourcesLocal price · YTD returnneutral +0.7%Non-operating security uses macro/market evidence until underlying exposure data is added.As of 2026-05-21 | needs review2026-05-23 |
| CAICaris Life Sciences Inc.1.00% weight | neutral | positive | positive | neutral | positive | positive | low | high | high83 | Latest SEC periodic filing is 10-Q filed 2026-05-08 for period 2026-03-31. Fundamental signals need caution based on available SEC XBRL facts. | SEC XBRL revenue $216.2M for 2026-03-31, +78.8% vs comparison period.Operating income $5.3M for 2026-03-31, +109.1% vs comparison period.Net income loss narrowed to -$510,000 for 2026-03-31, +99.5% improvement vs comparison period. | 6 sourcesSEC · Latest filingneutral 10-Q filed 2026-05-08Period 2026-03-31.As of 2026-05-08 SEC · Revenue trendpositive +78.8%Revenue $216.2M for 2026-03-31.As of 2026-03-31 SEC · Operating incomepositive $5.3M+109.1% versus comparison period.As of 2026-03-31 SEC · Net incomeneutral -$510,000+99.5% versus comparison period.As of 2026-03-31 SEC · Cashpositive $819.9MLatest usable SEC cash fact.As of 2026-03-31 | auto collected2026-05-23 |
| QSRRestaurant Brands Internationa0.99% weight | negative | negative | negative | neutral | positive | positive | medium | medium | high79 | Latest SEC periodic filing is 10-Q filed 2026-05-06 for period 2026-03-31. Fundamental signals need caution based on available SEC XBRL facts. | Operating income $606.0M for 2026-03-31, +39.3% vs comparison period. | 5 sourcesSEC · Latest filingneutral 10-Q filed 2026-05-06Period 2026-03-31.As of 2026-05-06 SEC · Revenue trendneutral +7.3%Revenue $2.26B for 2026-03-31.As of 2026-03-31 SEC · Operating incomepositive $606.0M+39.3% versus comparison period.As of 2026-03-31 SEC · Net incomeneutral $139.0M-45.9% versus comparison period.As of 2020-12-31 Local price · YTD returnneutral +11.8%Latest local close 76.25 on 2026-05-21.As of 2026-05-21 | auto collected2026-05-23 |
| RVMDRevolution Medicines Inc0.91% weight | negative | negative | negative | neutral | negative | negative | high | high | high83 | Latest SEC periodic filing is 10-Q filed 2026-05-06 for period 2026-03-31. Fundamental signals need caution based on available SEC XBRL facts. | Local price snapshot shows +93.0% YTD return, confirming market momentum but adding valuation pressure.Latest SEC cash fact is $440.9M as of 2026-03-31. | 6 sourcesSEC · Latest filingneutral 10-Q filed 2026-05-06Period 2026-03-31.As of 2026-05-06 SEC · Revenue trendneutral -Revenue $0 for 2024-09-30.As of 2024-09-30 SEC · Operating incomenegative -$445.2M-84.9% versus comparison period.As of 2026-03-31 SEC · Net incomenegative -$453.8M-112.6% versus comparison period.As of 2026-03-31 SEC · Cashpositive $440.9MLatest usable SEC cash fact.As of 2026-03-31 | auto collected2026-05-23 |
| LSCCLattice Semiconductor Corp.0.89% weight | neutral | positive | positive | positive | positive | positive | high | medium | high100 | Latest SEC periodic filing is 10-Q filed 2026-05-04 for period 2026-04-04. Fundamental signals skew positive based on available SEC XBRL facts. | SEC XBRL revenue $170.9M for 2026-04-04, +42.2% vs comparison period.Operating income $26.1M for 2026-04-04, +273.8% vs comparison period.Net income $21.8M for 2026-04-04, +334.4% vs comparison period. | 7 sourcesSEC · Latest filingneutral 10-Q filed 2026-05-04Period 2026-04-04.As of 2026-05-04 SEC · Revenue trendpositive +42.2%Revenue $170.9M for 2026-04-04.As of 2026-04-04 SEC · Gross marginneutral +68.8%Margin change +0.8% points versus comparison period.As of 2026-04-04 SEC · Operating incomepositive $26.1M+273.8% versus comparison period.As of 2026-04-04 SEC · Net incomepositive $21.8M+334.4% versus comparison period.As of 2026-04-04 | auto collected2026-05-23 |
| SNDKSandisk Corp0.72% weight | neutral | positive | positive | neutral | positive | positive | high | medium | high83 | Latest SEC periodic filing is 10-Q filed 2026-05-01 for period 2026-04-03. Fundamental signals skew positive based on available SEC XBRL facts. | SEC XBRL revenue $5.95B for 2026-04-03, +251.0% vs comparison period.Gross margin +78.4% for 2026-04-03, +55.8% point change.Operating income $4.11B for 2026-04-03, +318.6% vs comparison period. | 7 sourcesSEC · Latest filingneutral 10-Q filed 2026-05-01Period 2026-04-03.As of 2026-05-01 SEC · Revenue trendpositive +251.0%Revenue $5.95B for 2026-04-03.As of 2026-04-03 SEC · Gross marginpositive +78.4%Margin change +55.8% points versus comparison period.As of 2026-04-03 SEC · Operating incomepositive $4.11B+318.6% versus comparison period.As of 2026-04-03 SEC · Net incomepositive $3.62B+3127.7% versus comparison period.As of 2026-04-03 | auto collected2026-05-23 |
| UALUnited Airlines Holdings Inc0.72% weight | positive | positive | positive | neutral | positive | positive | low | low | high83 | Latest SEC periodic filing is 10-Q filed 2026-04-22 for period 2026-03-31. Fundamental signals skew positive based on available SEC XBRL facts. | SEC XBRL revenue $14.61B for 2026-03-31, +10.6% vs comparison period.Operating income $997.0M for 2026-03-31, +64.3% vs comparison period.Net income $699.0M for 2026-03-31, +80.6% vs comparison period. | 6 sourcesSEC · Latest filingneutral 10-Q filed 2026-04-22Period 2026-03-31.As of 2026-04-22 SEC · Revenue trendpositive +10.6%Revenue $14.61B for 2026-03-31.As of 2026-03-31 SEC · Operating incomepositive $997.0M+64.3% versus comparison period.As of 2026-03-31 SEC · Net incomepositive $699.0M+80.6% versus comparison period.As of 2026-03-31 SEC · Cashpositive $7.87BLatest usable SEC cash fact.As of 2026-03-31 | auto collected2026-05-23 |
| HUMHumana Inc0.71% weight | positive | positive | positive | neutral | positive | positive | low | low | high83 | Latest SEC periodic filing is 10-Q filed 2026-04-29 for period 2026-03-31. Fundamental signals skew positive based on available SEC XBRL facts. | SEC XBRL revenue $39.65B for 2026-03-31, +23.5% vs comparison period.Latest SEC cash fact is $4.95B as of 2026-03-31. | 6 sourcesSEC · Latest filingneutral 10-Q filed 2026-04-29Period 2026-03-31.As of 2026-04-29 SEC · Revenue trendpositive +23.5%Revenue $39.65B for 2026-03-31.As of 2026-03-31 SEC · Operating incomeneutral $1.75B-12.9% versus comparison period.As of 2026-03-31 SEC · Net incomeneutral $1.19B-4.7% versus comparison period.As of 2026-03-31 SEC · Cashpositive $4.95BLatest usable SEC cash fact.As of 2026-03-31 | auto collected2026-05-23 |
| WABWestinghouse Air Brake Technol0.70% weight | positive | positive | positive | neutral | positive | positive | medium | low | high83 | Latest SEC periodic filing is 10-Q filed 2026-04-22 for period 2026-03-31. Fundamental signals skew positive based on available SEC XBRL facts. | SEC XBRL revenue $2.95B for 2026-03-31, +13.0% vs comparison period. | 6 sourcesSEC · Latest filingneutral 10-Q filed 2026-04-22Period 2026-03-31.As of 2026-04-22 SEC · Revenue trendpositive +13.0%Revenue $2.95B for 2026-03-31.As of 2026-03-31 SEC · Gross marginneutral +36.0%Margin change +1.5% points versus comparison period.As of 2026-03-31 SEC · Operating incomeneutral $517.0M+9.1% versus comparison period.As of 2026-03-31 SEC · Net incomeneutral $362.0M+12.4% versus comparison period.As of 2026-03-31 | auto collected2026-05-23 |
| TWLOTwilio Inc0.68% weight | positive | positive | positive | positive | positive | positive | medium | low | high100 | Latest SEC periodic filing is 10-Q filed 2026-05-01 for period 2026-03-31. Fundamental signals skew positive based on available SEC XBRL facts. | SEC XBRL revenue $1.41B for 2026-03-31, +20.0% vs comparison period.Operating income $107.7M for 2026-03-31, +366.5% vs comparison period.Net income $90.1M for 2026-03-31, +350.3% vs comparison period. | 7 sourcesSEC · Latest filingneutral 10-Q filed 2026-05-01Period 2026-03-31.As of 2026-05-01 SEC · Revenue trendpositive +20.0%Revenue $1.41B for 2026-03-31.As of 2026-03-31 SEC · Gross marginneutral +48.6%Margin change -1.0% points versus comparison period.As of 2026-03-31 SEC · Operating incomepositive $107.7M+366.5% versus comparison period.As of 2026-03-31 SEC · Net incomepositive $90.1M+350.3% versus comparison period.As of 2026-03-31 | auto collected2026-05-23 |
| JBLJabil Inc0.65% weight | neutral | positive | positive | positive | positive | positive | high | medium | high100 | Latest SEC periodic filing is 10-Q filed 2026-04-08 for period 2026-02-28. Fundamental signals skew positive based on available SEC XBRL facts. | SEC XBRL revenue $8.28B for 2026-02-28, +23.1% vs comparison period.Operating income $374.0M for 2026-02-28, +52.7% vs comparison period.Net income $223.0M for 2026-02-28, +90.6% vs comparison period. | 7 sourcesSEC · Latest filingneutral 10-Q filed 2026-04-08Period 2026-02-28.As of 2026-04-08 SEC · Revenue trendpositive +23.1%Revenue $8.28B for 2026-02-28.As of 2026-02-28 SEC · Gross marginneutral +9.0%Margin change +0.4% points versus comparison period.As of 2026-02-28 SEC · Operating incomepositive $374.0M+52.7% versus comparison period.As of 2026-02-28 SEC · Net incomepositive $223.0M+90.6% versus comparison period.As of 2026-02-28 | auto collected2026-05-23 |
| SCCOSouthern Copper Corporation0.62% weight | positive | positive | positive | neutral | negative | positive | medium | low | high83 | Latest SEC periodic filing is 10-Q filed 2026-04-30 for period 2026-03-31. Fundamental signals skew positive based on available SEC XBRL facts. | SEC XBRL revenue $4.25B for 2026-03-31, +36.2% vs comparison period.Operating income $2.48B for 2026-03-31, +61.5% vs comparison period.Net income $621.4M for 2012-03-31, +29.9% vs comparison period. | 6 sourcesSEC · Latest filingneutral 10-Q filed 2026-04-30Period 2026-03-31.As of 2026-04-30 SEC · Revenue trendpositive +36.2%Revenue $4.25B for 2026-03-31.As of 2026-03-31 SEC · Operating incomepositive $2.48B+61.5% versus comparison period.As of 2026-03-31 SEC · Net incomepositive $621.4M+29.9% versus comparison period.As of 2012-03-31 SEC · Cashpositive $4.92BLatest usable SEC cash fact.As of 2026-03-31 | auto collected2026-05-23 |
| GSGiShares S&P GSCI Commodity-Ind0.61% weight | neutral | neutral | neutral | Not applicable | Not applicable | Not applicable | medium | neutral | low20 | This looks like an ETF, trust, index product, or macro exposure. Use underlying exposure, flows, country/commodity data, and liquidity rather than company financial statements. | Local price snapshot shows +44.9% YTD return. | 1 sourcesLocal price · YTD returnpositive +44.9%Non-operating security uses macro/market evidence until underlying exposure data is added.As of 2026-05-21 | needs review2026-05-23 |
| LINLinde Plc0.60% weight | neutral | neutral | neutral | neutral | positive | positive | medium | low | high83 | Latest SEC periodic filing is 10-Q filed 2026-05-01 for period 2026-03-31. Fundamental signals skew positive based on available SEC XBRL facts. | Latest SEC cash fact is $3.96B as of 2026-03-31. | 6 sourcesSEC · Latest filingneutral 10-Q filed 2026-05-01Period 2026-03-31.As of 2026-05-01 SEC · Revenue trendneutral +8.2%Revenue $8.78B for 2026-03-31.As of 2026-03-31 SEC · Operating incomeneutral $2.44B+11.7% versus comparison period.As of 2026-03-31 SEC · Net incomeneutral $1.86B+11.0% versus comparison period.As of 2026-03-31 SEC · Cashpositive $3.96BLatest usable SEC cash fact.As of 2026-03-31 | auto collected2026-05-23 |
| STXSeagate Technology Holdings Pl0.59% weight | neutral | positive | positive | neutral | positive | positive | high | medium | high83 | Latest SEC periodic filing is 10-Q filed 2026-04-29 for period 2026-04-03. Fundamental signals skew positive based on available SEC XBRL facts. | SEC XBRL revenue $3.11B for 2026-04-03, +44.1% vs comparison period.Operating income $998.0M for 2026-04-03, +131.6% vs comparison period.Net income $748.0M for 2026-04-03, +120.0% vs comparison period. | 6 sourcesSEC · Latest filingneutral 10-Q filed 2026-04-29Period 2026-04-03.As of 2026-04-29 SEC · Revenue trendpositive +44.1%Revenue $3.11B for 2026-04-03.As of 2026-04-03 SEC · Operating incomepositive $998.0M+131.6% versus comparison period.As of 2026-04-03 SEC · Net incomepositive $748.0M+120.0% versus comparison period.As of 2026-04-03 SEC · Cashpositive $1.15BLatest usable SEC cash fact.As of 2026-04-03 | auto collected2026-05-23 |
| CLFCleveland-Cliffs Inc0.58% weight | neutral | positive | positive | neutral | positive | positive | high | medium | high83 | Latest SEC periodic filing is 10-Q filed 2026-04-21 for period 2026-03-31. Fundamental signals skew positive based on available SEC XBRL facts. | Operating income loss narrowed to -$213.0M for 2026-03-31, +60.8% improvement vs comparison period.Net income loss narrowed to -$237.0M for 2026-03-31, +52.4% improvement vs comparison period.Latest SEC cash fact is $45.0M as of 2026-03-31. | 6 sourcesSEC · Latest filingneutral 10-Q filed 2026-04-21Period 2026-03-31.As of 2026-04-21 SEC · Revenue trendneutral +6.3%Revenue $4.92B for 2026-03-31.As of 2026-03-31 SEC · Operating incomeneutral -$213.0M+60.8% versus comparison period.As of 2026-03-31 SEC · Net incomeneutral -$237.0M+52.4% versus comparison period.As of 2026-03-31 SEC · Cashpositive $45.0MLatest usable SEC cash fact.As of 2026-03-31 | auto collected2026-05-23 |
| NUVBNuvation Bio Inc0.58% weight | neutral | positive | positive | neutral | negative | positive | low | high | high83 | Latest SEC periodic filing is 10-Q filed 2026-05-04 for period 2026-03-31. Fundamental signals need caution based on available SEC XBRL facts. | SEC XBRL revenue $83.2M for 2026-03-31, +2598.7% vs comparison period.Operating income $3.9M for 2026-03-31, +106.6% vs comparison period.Net income $5.4M for 2026-03-31, +110.1% vs comparison period. | 6 sourcesSEC · Latest filingneutral 10-Q filed 2026-05-04Period 2026-03-31.As of 2026-05-04 SEC · Revenue trendpositive +2598.7%Revenue $83.2M for 2026-03-31.As of 2026-03-31 SEC · Operating incomepositive $3.9M+106.6% versus comparison period.As of 2026-03-31 SEC · Net incomepositive $5.4M+110.1% versus comparison period.As of 2026-03-31 SEC · Cashpositive $125.4MLatest usable SEC cash fact.As of 2026-03-31 | auto collected2026-05-23 |
| BEBloom Energy Corp0.55% weight | neutral | positive | positive | positive | positive | positive | high | medium | high100 | Latest SEC periodic filing is 10-Q filed 2026-04-29 for period 2026-03-31. Fundamental signals skew positive based on available SEC XBRL facts. | SEC XBRL revenue $746.4M for 2026-03-31, +133.8% vs comparison period.Gross margin +30.2% for 2026-03-31, +2.4% point change.Operating income $72.2M for 2026-03-31, +478.6% vs comparison period. | 7 sourcesSEC · Latest filingneutral 10-Q filed 2026-04-29Period 2026-03-31.As of 2026-04-29 SEC · Revenue trendpositive +133.8%Revenue $746.4M for 2026-03-31.As of 2026-03-31 SEC · Gross marginpositive +30.2%Margin change +2.4% points versus comparison period.As of 2026-03-31 SEC · Operating incomepositive $72.2M+478.6% versus comparison period.As of 2026-03-31 SEC · Net incomeneutral -$57.1M-9.0% versus comparison period.As of 2022-09-30 | auto collected2026-05-23 |
| INTCIntel Corp0.54% weight | negative | negative | negative | positive | negative | positive | high | high | high100 | Latest SEC periodic filing is 10-Q filed 2026-04-24 for period 2026-03-28. Fundamental signals need caution based on available SEC XBRL facts. | Gross margin +39.4% for 2026-03-28, +2.5% point change.Local price snapshot shows +221.1% YTD return, confirming market momentum but adding valuation pressure.Latest SEC cash fact is $17.25B as of 2026-03-28. | 7 sourcesSEC · Latest filingneutral 10-Q filed 2026-04-24Period 2026-03-28.As of 2026-04-24 SEC · Revenue trendneutral +7.2%Revenue $13.58B for 2026-03-28.As of 2026-03-28 SEC · Gross marginpositive +39.4%Margin change +2.5% points versus comparison period.As of 2026-03-28 SEC · Operating incomenegative -$3.14B-941.9% versus comparison period.As of 2026-03-28 SEC · Net incomenegative -$3.73B-354.1% versus comparison period.As of 2026-03-28 | auto collected2026-05-23 |
| BLTEBelite Bio Inc0.50% weight | neutral | neutral | neutral | neutral | positive | neutral | medium | low | medium65 | Latest SEC periodic filing is 20-F filed 2026-03-31 for period 2025-12-31. Fundamental signals skew positive based on available SEC XBRL facts. | Latest SEC cash fact is $352.9M as of 2025-12-31. | 3 sourcesSEC · Latest filingneutral 20-F filed 2026-03-31Period 2025-12-31.As of 2026-03-31 SEC · Cashpositive $352.9MLatest usable SEC cash fact.As of 2025-12-31 Local price · YTD returnneutral -9.8%Latest local close 144.25 on 2026-05-21.As of 2026-05-21 | auto collected2026-05-23 |
| PTGXProtagonist Therapeutics Inc0.50% weight | neutral | positive | positive | neutral | positive | negative | high | medium | high83 | Latest SEC periodic filing is 10-Q filed 2026-05-05 for period 2026-03-31. Fundamental signals skew positive based on available SEC XBRL facts. | Operating income loss narrowed to -$3.6M for 2026-03-31, +81.1% improvement vs comparison period.Net income $3.8M for 2026-03-31, +132.5% vs comparison period.Latest SEC cash fact is $193.7M as of 2026-03-31. | 6 sourcesSEC · Latest filingneutral 10-Q filed 2026-05-05Period 2026-03-31.As of 2026-05-05 SEC · Revenue trendneutral -Revenue $8.8M for 2017-09-30.As of 2017-09-30 SEC · Operating incomeneutral -$3.6M+81.1% versus comparison period.As of 2026-03-31 SEC · Net incomepositive $3.8M+132.5% versus comparison period.As of 2026-03-31 SEC · Cashpositive $193.7MLatest usable SEC cash fact.As of 2026-03-31 | auto collected2026-05-23 |
| UUnity Software Inc0.48% weight | negative | negative | negative | neutral | positive | positive | low | high | high83 | Latest SEC periodic filing is 10-Q filed 2026-05-07 for period 2026-03-31. Fundamental signals need caution based on available SEC XBRL facts. | SEC XBRL revenue $508.2M for 2026-03-31, +16.8% vs comparison period.Latest SEC cash fact is $2.14B as of 2026-03-31. | 7 sourcesSEC · Latest filingneutral 10-Q filed 2026-05-07Period 2026-03-31.As of 2026-05-07 SEC · Revenue trendpositive +16.8%Revenue $508.2M for 2026-03-31.As of 2026-03-31 SEC · Gross marginnegative +30.8%Margin change -43.0% points versus comparison period.As of 2026-03-31 SEC · Operating incomenegative -$351.4M-174.7% versus comparison period.As of 2026-03-31 SEC · Net incomenegative -$347.6M-347.7% versus comparison period.As of 2026-03-31 | auto collected2026-05-23 |
| ARMArm Holdings plc0.48% weight | negative | neutral | neutral | negative | positive | positive | high | medium | medium68 | Latest SEC periodic filing is 20-F filed 2025-05-28 for period 2025-03-31. Fundamental signals skew positive based on available SEC XBRL facts. | Local price snapshot shows +172.8% YTD return, confirming market momentum but adding valuation pressure.Latest SEC cash fact is $2.08B as of 2025-03-31. | 3 sourcesSEC · Latest filingneutral 20-F filed 2025-05-28Period 2025-03-31.As of 2025-05-28 SEC · Cashpositive $2.08BLatest usable SEC cash fact.As of 2025-03-31 Local price · YTD returnpositive +172.8%Latest local close 298.23 on 2026-05-21.As of 2026-05-21 | auto collected2026-05-23 |
| OLMAOlema Pharmaceuticals Inc0.44% weight | negative | negative | negative | No explicit guide | negative | neutral | low | high | high79 | Latest SEC periodic filing is 10-Q filed 2026-05-12 for period 2026-03-31. Fundamental signals need caution based on available SEC XBRL facts. | Latest SEC cash fact is $52.5M as of 2026-03-31. | 5 sourcesSEC · Latest filingneutral 10-Q filed 2026-05-12Period 2026-03-31.As of 2026-05-12 SEC · Operating incomenegative -$58.0M-66.3% versus comparison period.As of 2026-03-31 SEC · Net incomenegative -$53.1M-74.7% versus comparison period.As of 2026-03-31 SEC · Cashpositive $52.5MLatest usable SEC cash fact.As of 2026-03-31 Local price · YTD returnnegative -43.8%Latest local close 14.06 on 2026-05-21.As of 2026-05-21 | auto collected2026-05-23 |
| QQnity Electronics Inc0.43% weight | neutral | positive | positive | positive | positive | positive | high | medium | high99 | Latest SEC periodic filing is 10-Q filed 2026-05-12 for period 2026-03-31. Fundamental signals skew positive based on available SEC XBRL facts. | SEC XBRL revenue $1.31B for 2026-03-31, +17.6% vs comparison period.Local price snapshot shows +87.1% YTD return, confirming market momentum but adding valuation pressure.Latest SEC cash fact is $857.0M as of 2026-03-31. | 5 sourcesSEC · Latest filingneutral 10-Q filed 2026-05-12Period 2026-03-31.As of 2026-05-12 SEC · Revenue trendpositive +17.6%Revenue $1.31B for 2026-03-31.As of 2026-03-31 SEC · Net incomeneutral $211.0M+6.0% versus comparison period.As of 2025-09-30 SEC · Cashpositive $857.0MLatest usable SEC cash fact.As of 2026-03-31 Local price · YTD returnpositive +87.1%Latest local close 152.76 on 2026-05-21.As of 2026-05-21 | auto collected2026-05-23 |
| ADMAADMA Biologics Inc0.41% weight | neutral | positive | positive | neutral | positive | positive | low | high | high83 | Latest SEC periodic filing is 10-Q filed 2026-05-06 for period 2026-03-31. Fundamental signals need caution based on available SEC XBRL facts. | Gross margin +70.5% for 2026-03-31, +17.3% point change.Operating income $58.3M for 2026-03-31, +67.1% vs comparison period.Net income $45.3M for 2026-03-31, +68.5% vs comparison period. | 7 sourcesSEC · Latest filingneutral 10-Q filed 2026-05-06Period 2026-03-31.As of 2026-05-06 SEC · Revenue trendneutral -0.3%Revenue $114.5M for 2026-03-31.As of 2026-03-31 SEC · Gross marginpositive +70.5%Margin change +17.3% points versus comparison period.As of 2026-03-31 SEC · Operating incomepositive $58.3M+67.1% versus comparison period.As of 2026-03-31 SEC · Net incomepositive $45.3M+68.5% versus comparison period.As of 2026-03-31 | auto collected2026-05-23 |
| XENEXenon Pharmaceuticals Inc0.41% weight | negative | negative | negative | neutral | negative | positive | medium | high | high83 | Latest SEC periodic filing is 10-Q filed 2026-05-07 for period 2026-03-31. Fundamental signals need caution based on available SEC XBRL facts. | Latest SEC cash fact is $545.9M as of 2026-03-31. | 6 sourcesSEC · Latest filingneutral 10-Q filed 2026-05-07Period 2026-03-31.As of 2026-05-07 SEC · Revenue trendneutral -Revenue $264,000 for 2017-09-30.As of 2017-09-30 SEC · Operating incomenegative -$112.3M-54.4% versus comparison period.As of 2026-03-31 SEC · Net incomenegative -$102.3M-57.3% versus comparison period.As of 2026-03-31 SEC · Cashpositive $545.9MLatest usable SEC cash fact.As of 2026-03-31 | auto collected2026-05-23 |
| JBSJBS N.V.0.35% weight | neutral | neutral | neutral | neutral | negative | positive | high | medium | medium58 | Latest SEC periodic filing is 20-F filed 2026-03-25 for period 2025-12-31. Available SEC XBRL facts are neutral or incomplete for the watched KPI template. | Identify whether the company's core operating drivers are improving enough to support continued ownership. | 2 sourcesSEC · Latest filingneutral 20-F filed 2026-03-25Period 2025-12-31.As of 2026-03-25 Local price · YTD returnneutral -7.9%Latest local close 13.28 on 2026-05-21.As of 2026-05-21 | auto collected2026-05-23 |
| DAKTDaktronics Inc0.33% weight | neutral | negative | neutral | neutral | positive | positive | medium | medium | high83 | Latest SEC periodic filing is 10-Q filed 2026-03-04 for period 2026-01-31. Fundamental signals need caution based on available SEC XBRL facts. | SEC XBRL revenue $181.9M for 2026-01-31, +21.6% vs comparison period.Operating income $1.9M for 2026-01-31, +153.0% vs comparison period.Latest SEC cash fact is $144.4M as of 2026-01-31. | 7 sourcesSEC · Latest filingneutral 10-Q filed 2026-03-04Period 2026-01-31.As of 2026-03-04 SEC · Revenue trendpositive +21.6%Revenue $181.9M for 2026-01-31.As of 2026-01-31 SEC · Gross marginneutral +24.0%Margin change -0.6% points versus comparison period.As of 2026-01-31 SEC · Operating incomepositive $1.9M+153.0% versus comparison period.As of 2026-01-31 SEC · Net incomeneutral $3.0M-82.8% versus comparison period.As of 2026-01-31 | auto collected2026-05-23 |
| NETCloudflare Inc0.32% weight | negative | negative | negative | neutral | positive | positive | high | high | high83 | Latest SEC periodic filing is 10-Q filed 2026-05-08 for period 2026-03-31. Fundamental signals need caution based on available SEC XBRL facts. | SEC XBRL revenue $639.8M for 2026-03-31, +33.5% vs comparison period.Net income loss narrowed to -$22.9M for 2026-03-31, +40.4% improvement vs comparison period.Latest SEC cash fact is $932.2M as of 2026-03-31. | 7 sourcesSEC · Latest filingneutral 10-Q filed 2026-05-08Period 2026-03-31.As of 2026-05-08 SEC · Revenue trendpositive +33.5%Revenue $639.8M for 2026-03-31.As of 2026-03-31 SEC · Gross marginnegative +71.2%Margin change -4.7% points versus comparison period.As of 2026-03-31 SEC · Operating incomenegative -$62.0M-16.4% versus comparison period.As of 2026-03-31 SEC · Net incomeneutral -$22.9M+40.4% versus comparison period.As of 2026-03-31 | auto collected2026-05-23 |
| LYBLyondellBasell Industries NV0.31% weight | negative | negative | negative | neutral | positive | positive | high | high | high83 | Latest SEC periodic filing is 10-Q filed 2026-05-01 for period 2026-03-31. Fundamental signals need caution based on available SEC XBRL facts. | Operating income $239.0M for 2026-03-31, +109.6% vs comparison period.Local price snapshot shows +61.8% YTD return, confirming market momentum but adding valuation pressure.Latest SEC cash fact is $2.63B as of 2026-03-31. | 6 sourcesSEC · Latest filingneutral 10-Q filed 2026-05-01Period 2026-03-31.As of 2026-05-01 SEC · Revenue trendnegative -6.3%Revenue $7.20B for 2026-03-31.As of 2026-03-31 SEC · Operating incomepositive $239.0M+109.6% versus comparison period.As of 2026-03-31 SEC · Net incomeneutral $817.0M-33.6% versus comparison period.As of 2019-03-31 SEC · Cashpositive $2.63BLatest usable SEC cash fact.As of 2026-03-31 | auto collected2026-05-23 |
| VISTVista Energy S.A.B. de C.V0.30% weight | neutral | neutral | neutral | neutral | positive | positive | high | medium | medium58 | Latest SEC periodic filing is 20-F filed 2026-04-28 for period 2025-12-31. Fundamental signals skew positive based on available SEC XBRL facts. | Local price snapshot shows +55.2% YTD return, confirming market momentum but adding valuation pressure. | 2 sourcesSEC · Latest filingneutral 20-F filed 2026-04-28Period 2025-12-31.As of 2026-04-28 Local price · YTD returnpositive +55.2%Latest local close 75.54 on 2026-05-21.As of 2026-05-21 | auto collected2026-05-23 |
| TWSTTwist Bioscience Corp0.29% weight | neutral | neutral | neutral | neutral | negative | positive | high | medium | high79 | Latest SEC periodic filing is 10-Q filed 2026-05-04 for period 2026-03-31. Fundamental signals skew positive based on available SEC XBRL facts. | Local price snapshot shows +85.5% YTD return, confirming market momentum but adding valuation pressure.Latest SEC cash fact is $122.7M as of 2026-03-31. | 5 sourcesSEC · Latest filingneutral 10-Q filed 2026-05-04Period 2026-03-31.As of 2026-05-04 SEC · Operating incomeneutral -$45.9M-10.4% versus comparison period.As of 2026-03-31 SEC · Net incomeneutral -$44.0M-11.9% versus comparison period.As of 2026-03-31 SEC · Cashpositive $122.7MLatest usable SEC cash fact.As of 2026-03-31 Local price · YTD returnpositive +85.5%Latest local close 58.835 on 2026-05-21.As of 2026-05-21 | auto collected2026-05-23 |
| COHRCoherent Corp0.28% weight | negative | negative | neutral | neutral | positive | positive | high | high | high83 | Latest SEC periodic filing is 10-Q filed 2026-05-06 for period 2026-03-31. Fundamental signals need caution based on available SEC XBRL facts. | SEC XBRL revenue $1.81B for 2026-03-31, +20.5% vs comparison period.Net income $191.4M for 2026-03-31, +1118.3% vs comparison period.Local price snapshot shows +104.8% YTD return, confirming market momentum but adding valuation pressure. | 6 sourcesSEC · Latest filingneutral 10-Q filed 2026-05-06Period 2026-03-31.As of 2026-05-06 SEC · Revenue trendpositive +20.5%Revenue $1.81B for 2026-03-31.As of 2026-03-31 SEC · Operating incomeneutral $22.3M-66.9% versus comparison period.As of 2024-03-31 SEC · Net incomepositive $191.4M+1118.3% versus comparison period.As of 2026-03-31 SEC · Cashpositive $1.59BLatest usable SEC cash fact.As of 2026-03-31 | auto collected2026-05-23 |
| AMZNAmazon.com Inc0.28% weight | positive | positive | positive | neutral | positive | positive | medium | low | high83 | Latest SEC periodic filing is 10-Q filed 2026-04-30 for period 2026-03-31. Fundamental signals skew positive based on available SEC XBRL facts. | SEC XBRL revenue $181.52B for 2026-03-31, +16.6% vs comparison period.Operating income $23.85B for 2026-03-31, +29.6% vs comparison period.Net income $30.25B for 2026-03-31, +76.7% vs comparison period. | 6 sourcesSEC · Latest filingneutral 10-Q filed 2026-04-30Period 2026-03-31.As of 2026-04-30 SEC · Revenue trendpositive +16.6%Revenue $181.52B for 2026-03-31.As of 2026-03-31 SEC · Operating incomepositive $23.85B+29.6% versus comparison period.As of 2026-03-31 SEC · Net incomepositive $30.25B+76.7% versus comparison period.As of 2026-03-31 SEC · Cashpositive $101.82BLatest usable SEC cash fact.As of 2026-03-31 | auto collected2026-05-23 |
| CLSCelestica Inc0.28% weight | positive | positive | positive | positive | positive | positive | medium | low | high100 | Latest SEC periodic filing is 10-Q filed 2026-04-27 for period 2026-03-31. Fundamental signals skew positive based on available SEC XBRL facts. | SEC XBRL revenue $4.05B for 2026-03-31, +52.8% vs comparison period.Operating income $272.1M for 2026-03-31, +111.3% vs comparison period.Net income $212.3M for 2026-03-31, +146.3% vs comparison period. | 7 sourcesSEC · Latest filingneutral 10-Q filed 2026-04-27Period 2026-03-31.As of 2026-04-27 SEC · Revenue trendpositive +52.8%Revenue $4.05B for 2026-03-31.As of 2026-03-31 SEC · Gross marginneutral +10.8%Margin change +0.5% points versus comparison period.As of 2026-03-31 SEC · Operating incomepositive $272.1M+111.3% versus comparison period.As of 2026-03-31 SEC · Net incomepositive $212.3M+146.3% versus comparison period.As of 2026-03-31 | auto collected2026-05-23 |
| STUBStubhub Holdings Inc.0.25% weight | positive | positive | positive | neutral | positive | positive | low | low | high83 | Latest SEC periodic filing is 10-Q filed 2026-05-14 for period 2026-03-31. Fundamental signals skew positive based on available SEC XBRL facts. | SEC XBRL revenue $446.0M for 2026-03-31, +12.2% vs comparison period.Net income $48.0M for 2026-03-31, +316.6% vs comparison period.Latest SEC cash fact is $1.53B as of 2026-03-31. | 6 sourcesSEC · Latest filingneutral 10-Q filed 2026-05-14Period 2026-03-31.As of 2026-05-14 SEC · Revenue trendpositive +12.2%Revenue $446.0M for 2026-03-31.As of 2026-03-31 SEC · Operating incomeneutral $25.8M-3.8% versus comparison period.As of 2026-03-31 SEC · Net incomepositive $48.0M+316.6% versus comparison period.As of 2026-03-31 SEC · Cashpositive $1.53BLatest usable SEC cash fact.As of 2026-03-31 | auto collected2026-05-23 |
| DBVTDBV Technologies0.24% weight | negative | negative | negative | neutral | negative | positive | medium | high | high83 | Latest SEC periodic filing is 10-Q filed 2026-04-30 for period 2026-03-31. Fundamental signals need caution based on available SEC XBRL facts. | SEC XBRL revenue $900,000 for 2026-03-31, +12.5% vs comparison period.Latest SEC cash fact is $229.2M as of 2026-03-31. | 6 sourcesSEC · Latest filingneutral 10-Q filed 2026-04-30Period 2026-03-31.As of 2026-04-30 SEC · Revenue trendpositive +12.5%Revenue $900,000 for 2026-03-31.As of 2026-03-31 SEC · Operating incomenegative -$47.9M-80.1% versus comparison period.As of 2026-03-31 SEC · Net incomenegative -$47.6M-75.6% versus comparison period.As of 2026-03-31 SEC · Cashpositive $229.2MLatest usable SEC cash fact.As of 2026-03-31 | auto collected2026-05-23 |
| MUMicron Technology Inc0.23% weight | neutral | positive | positive | neutral | positive | positive | high | medium | high83 | Latest SEC periodic filing is 10-Q filed 2026-03-19 for period 2026-02-26. Fundamental signals skew positive based on available SEC XBRL facts. | SEC XBRL revenue $23.86B for 2026-02-26, +196.3% vs comparison period.Gross margin +74.4% for 2026-02-26, +37.6% point change.Operating income $16.14B for 2026-02-26, +810.0% vs comparison period. | 7 sourcesSEC · Latest filingneutral 10-Q filed 2026-03-19Period 2026-02-26.As of 2026-03-19 SEC · Revenue trendpositive +196.3%Revenue $23.86B for 2026-02-26.As of 2026-02-26 SEC · Gross marginpositive +74.4%Margin change +37.6% points versus comparison period.As of 2026-02-26 SEC · Operating incomepositive $16.14B+810.0% versus comparison period.As of 2026-02-26 SEC · Net incomepositive $13.79B+770.8% versus comparison period.As of 2026-02-26 | auto collected2026-05-23 |
| SATSEchoStar Corp0.21% weight | negative | negative | neutral | neutral | negative | negative | medium | medium | high83 | Latest SEC periodic filing is 10-Q filed 2026-05-11 for period 2026-03-31. Fundamental signals need caution based on available SEC XBRL facts. | Operating income $392.8M for 2026-03-31, +545.7% vs comparison period.Net income loss narrowed to -$146.9M for 2026-03-31, +27.5% improvement vs comparison period.Latest SEC cash fact is $1.34B as of 2026-03-31. | 6 sourcesSEC · Latest filingneutral 10-Q filed 2026-05-11Period 2026-03-31.As of 2026-05-11 SEC · Revenue trendnegative -5.2%Revenue $3.67B for 2026-03-31.As of 2026-03-31 SEC · Operating incomepositive $392.8M+545.7% versus comparison period.As of 2026-03-31 SEC · Net incomeneutral -$146.9M+27.5% versus comparison period.As of 2026-03-31 SEC · Cashpositive $1.34BLatest usable SEC cash fact.As of 2026-03-31 | auto collected2026-05-23 |
| ALMAlmonty Industries Inc0.20% weight | neutral | neutral | neutral | No explicit guide | positive | neutral | high | medium | medium58 | Latest SEC periodic filing is 40-F filed 2026-03-19 for period 2025-12-31. Fundamental signals skew positive based on available SEC XBRL facts. | Local price snapshot shows +113.3% YTD return, confirming market momentum but adding valuation pressure. | 2 sourcesSEC · Latest filingneutral 40-F filed 2026-03-19Period 2025-12-31.As of 2026-03-19 Local price · YTD returnpositive +113.3%Latest local close 18.79 on 2026-05-21.As of 2026-05-21 | auto collected2026-05-23 |
| PCTPureCycle Technologies Inc.0.15% weight | negative | negative | negative | neutral | negative | positive | medium | medium | high83 | Latest SEC periodic filing is 10-Q filed 2026-05-06 for period 2026-03-31. Fundamental signals need caution based on available SEC XBRL facts. | SEC XBRL revenue $4.1M for 2026-03-31, +161.2% vs comparison period.Latest SEC cash fact is $90.2M as of 2026-03-31. | 6 sourcesSEC · Latest filingneutral 10-Q filed 2026-05-06Period 2026-03-31.As of 2026-05-06 SEC · Revenue trendpositive +161.2%Revenue $4.1M for 2026-03-31.As of 2026-03-31 SEC · Operating incomeneutral -$41.8M-10.8% versus comparison period.As of 2026-03-31 SEC · Net incomenegative -$33.4M-478.6% versus comparison period.As of 2026-03-31 SEC · Cashpositive $90.2MLatest usable SEC cash fact.As of 2026-03-31 | auto collected2026-05-23 |
| LITELumentum Holdings Inc0.14% weight | neutral | positive | positive | neutral | positive | positive | high | medium | high83 | Latest SEC periodic filing is 10-Q filed 2026-05-06 for period 2026-03-28. Fundamental signals skew positive based on available SEC XBRL facts. | SEC XBRL revenue $425.2M for 2025-03-29, +16.0% vs comparison period.Operating income $174.5M for 2026-03-28, +562.9% vs comparison period.Net income $144.2M for 2026-03-28, +84.4% vs comparison period. | 6 sourcesSEC · Latest filingneutral 10-Q filed 2026-05-06Period 2026-03-28.As of 2026-05-06 SEC · Revenue trendpositive +16.0%Revenue $425.2M for 2025-03-29.As of 2025-03-29 SEC · Operating incomepositive $174.5M+562.9% versus comparison period.As of 2026-03-28 SEC · Net incomepositive $144.2M+84.4% versus comparison period.As of 2026-03-28 SEC · Cashpositive $2.62BLatest usable SEC cash fact.As of 2026-03-28 | auto collected2026-05-23 |
| MELIMercadoLibre Inc0.14% weight | negative | negative | negative | neutral | negative | positive | medium | medium | high83 | Latest SEC periodic filing is 10-Q filed 2026-05-08 for period 2026-03-31. Fundamental signals need caution based on available SEC XBRL facts. | SEC XBRL revenue $6.07B for 2026-03-31, +44.7% vs comparison period.Latest SEC cash fact is $3.68B as of 2026-03-31. | 7 sourcesSEC · Latest filingneutral 10-Q filed 2026-05-08Period 2026-03-31.As of 2026-05-08 SEC · Revenue trendpositive +44.7%Revenue $6.07B for 2026-03-31.As of 2026-03-31 SEC · Gross marginnegative +63.7%Margin change -2.4% points versus comparison period.As of 2026-03-31 SEC · Operating incomeneutral $611.0M-19.9% versus comparison period.As of 2026-03-31 SEC · Net incomeneutral $417.0M-15.6% versus comparison period.As of 2026-03-31 | auto collected2026-05-23 |
| SOLSSolstice Advanced Materials In0.14% weight | negative | negative | negative | neutral | positive | positive | high | high | high79 | Latest SEC periodic filing is 10-Q filed 2026-05-06 for period 2026-03-31. Fundamental signals need caution based on available SEC XBRL facts. | SEC XBRL revenue $991.0M for 2026-03-31, +10.5% vs comparison period.Local price snapshot shows +63.4% YTD return, confirming market momentum but adding valuation pressure.Latest SEC cash fact is $642.0M as of 2026-03-31. | 5 sourcesSEC · Latest filingneutral 10-Q filed 2026-05-06Period 2026-03-31.As of 2026-05-06 SEC · Revenue trendpositive +10.5%Revenue $991.0M for 2026-03-31.As of 2026-03-31 SEC · Net incomeneutral $85.0M-36.6% versus comparison period.As of 2026-03-31 SEC · Cashpositive $642.0MLatest usable SEC cash fact.As of 2026-03-31 Local price · YTD returnpositive +63.4%Latest local close 79.38 on 2026-05-21.As of 2026-05-21 | auto collected2026-05-23 |
| WLKWestlake Corporation0.07% weight | negative | negative | negative | neutral | positive | positive | high | high | high83 | Latest SEC periodic filing is 10-Q filed 2026-05-06 for period 2026-03-31. Fundamental signals need caution based on available SEC XBRL facts. | Latest SEC cash fact is $2.27B as of 2026-03-31. | 7 sourcesSEC · Latest filingneutral 10-Q filed 2026-05-06Period 2026-03-31.As of 2026-05-06 SEC · Revenue trendnegative -6.8%Revenue $2.65B for 2026-03-31.As of 2026-03-31 SEC · Gross marginnegative +4.2%Margin change -3.9% points versus comparison period.As of 2026-03-31 SEC · Operating incomenegative -$172.0M-437.5% versus comparison period.As of 2026-03-31 SEC · Net incomenegative -$169.0M-322.5% versus comparison period.As of 2026-03-31 | auto collected2026-05-23 |
| WVEWAVE Life Sciences Ltd0.04% weight | neutral | positive | positive | neutral | negative | negative | low | high | high83 | Latest SEC periodic filing is 10-Q filed 2026-04-28 for period 2026-03-31. Fundamental signals need caution based on available SEC XBRL facts. | SEC XBRL revenue $38.2M for 2026-03-31, +316.9% vs comparison period.Operating income loss narrowed to -$31.3M for 2026-03-31, +37.2% improvement vs comparison period.Net income loss narrowed to -$26.1M for 2026-03-31, +44.4% improvement vs comparison period. | 6 sourcesSEC · Latest filingneutral 10-Q filed 2026-04-28Period 2026-03-31.As of 2026-04-28 SEC · Revenue trendpositive +316.9%Revenue $38.2M for 2026-03-31.As of 2026-03-31 SEC · Operating incomeneutral -$31.3M+37.2% versus comparison period.As of 2026-03-31 SEC · Net incomeneutral -$26.1M+44.4% versus comparison period.As of 2026-03-31 SEC · Cashpositive $544.6MLatest usable SEC cash fact.As of 2026-03-31 | auto collected2026-05-23 |
This local signal layer separates company guidance from analyst expectations, then applies evidence-quality scoring before it affects the prediction model.
Company drivers
Company Driver Targets
65Current Duquesne common-share holdings
6Manual override templates in v0.1
2Need company-level review first
KPI draftDefines what to watch before scoring recent company change
| Name | Basis | Driver target | Primary KPIs | Earnings triggers | Key risks | Valuation |
|---|---|---|---|---|---|---|
| NTRANatera Inc18.14% weight | Tickerdraft | Confirm that testing volume, oncology adoption, gross margin, and revenue guidance continue to validate the growth thesis. | Test volume growthOncology revenue growthGross marginCash burnRevenue guidance | Test volume and oncology revenue accelerateFull-year revenue guidance is raisedGross margin improves while cash burn narrows | Reimbursement pressureLitigation/regulatory riskCompetition | ntm_ev_salesrevenue_growth_adjusted_psgross_margin_path |
| INSMInsmed Inc5.59% weight | Industrydraft | Confirm that product demand and pipeline/regulatory progress offset pricing, patent, and litigation risks. | Product revenue growthPipeline milestonesMargin/cost progressBalance sheetGuidance revision | Product sales beat and guidance is raisedPipeline/regulatory event improves probability of successLitigation, pricing, or patent risk worsens | Patent cliffsPricing pressureRegulatory setbacks | ntm_peev_ebitdafree_cash_flow_yield |
| TSMTaiwan Semiconductor Manufactu4.96% weight | Tickerdraft | Confirm that AI/HPC demand and leading-edge utilization offset cyclicality and geopolitical risk. | HPC/AI revenue growthGross marginCapex/capacity planAdvanced-node mixGuidance revision | AI/HPC revenue and margin outlook improveAdvanced-node utilization risesCapex plan supports durable demand | Taiwan geopolitical riskSmartphone cycle weaknessCapex intensity | ntm_peev_ebitdacapex_adjusted_fcf |
| YPFYPF S.A. ADR4.43% weight | Industrydraft | Confirm that cash flow and capital allocation stay strong across the commodity cycle. | Oil/gas price realizationProduction growthFree cash flowCapex disciplineBuyback/dividend | Oil/gas price backdrop improvesProduction and FCF beat expectationsBuyback or dividend intensity rises | Oil price declinePolitical/regulatory riskCapex inflation | ev_ebitdafcf_yieldnet_debt_to_ebitda |
| EWZiShares MSCI Brazil ETF3.91% weight | Industrydraft | Track the macro variables and underlying exposure that explain the ETF or financial vehicle. | Underlying index returnCurrency/rate signalCommodity/country signalFlows/liquidityRelative strength | Underlying market breaks out or rolls overCurrency/rate/commodity backdrop shiftsETF liquidity or flows become stressed | Country riskCurrency riskLiquidity risk | nav_discount_premiumunderlying_perelative_strength |
| TBBBBBB Foods Inc3.26% weight | Sectordraft | Confirm that demand and margins improve without excessive valuation pressure. | Same-store/revenue growthGross marginOperating marginTraffic/ordersGuidance revision | Revenue and traffic/orders accelerateMargins expandGuidance improves | Consumer slowdownPromotional intensityInput cost pressure | ntm_peev_ebitdantm_ev_sales |
| AAAlcoa Corp2.93% weight | Sectordraft | Confirm that realized prices, volumes, and margins support a materials-cycle thesis. | Realized priceVolume growthCash costFree cash flowGuidance revision | Commodity price and volume improve togetherCash costs fall or FCF risesManagement raises outlook | Commodity price declineCost inflationDemand slowdown | ev_ebitdafcf_yieldprice_to_book |
| NAMSNewAmsterdam Pharma Company NV2.91% weight | Industrydraft | Track whether the key product, pipeline, or platform is being validated by data and commercial execution. | Clinical/platform milestonesRevenue/volume growthGross marginCash runwayGuidance/pipeline update | Clinical data, FDA, or reimbursement update changes probability of successCommercial launch or test volume acceleratesCash burn improves or financing risk falls | Clinical failureRegulatory delayDilution | ev_salescash_runwayrisk_adjusted_pipeline_value |
| SESea Ltd2.70% weight | Sectordraft | Confirm that growth quality and profitability are improving without excessive valuation pressure. | Revenue growthRetention/usageOperating marginFCF marginGuidance revision | Revenue or usage growth reacceleratesOperating margin or FCF margin expandsAI/product commentary improves demand outlook | Growth decelerationHigh valuationCompetition | ntm_ev_salesrule_of_40fcf_yield |
| STMSTMicroelectronics N.V. ADS AD2.67% weight | Industrydraft | Confirm that demand, margins, and inventory are improving enough to justify continued exposure. | Revenue growthGross marginAI/data-center exposureInventory/backlogGuidance revision | Revenue and gross margin beat with raised outlookAI or data-center demand commentary improvesInventory correction ends or backlog strengthens | Semiconductor cycle rolloverCustomer concentrationInventory correction | ntm_pentm_ev_salesgross_margin_adjusted_growth |
| WWDWoodward Inc2.24% weight | Sectordraft | Confirm that backlog, margins, and guidance support continued earnings growth. | Orders/backlogOrganic revenue growthOperating marginBook-to-billGuidance revision | Orders/backlog and margins improveBook-to-bill remains above oneGuidance is raised | Industrial cycle slowdownSupply-chain issuesInput cost pressure | ntm_peev_ebitdafcf_yield |
| TEVATeva Pharmaceutical Industries2.12% weight | Industrydraft | Track whether the key product, pipeline, or platform is being validated by data and commercial execution. | Clinical/platform milestonesRevenue/volume growthGross marginCash runwayGuidance/pipeline update | Clinical data, FDA, or reimbursement update changes probability of successCommercial launch or test volume acceleratesCash burn improves or financing risk falls | Clinical failureRegulatory delayDilution | ev_salescash_runwayrisk_adjusted_pipeline_value |
| ROKURoku Inc2.10% weight | Industrydraft | Track whether order growth, backlog, and margins confirm a hardware cycle upswing. | Orders/backlogRevenue growthGross marginInventoryGuidance revision | Backlog/orders accelerateAI, optical, networking, or storage demand strengthensGross margin expands | Hardware cycle reversalCustomer concentrationInventory correction | ntm_peev_ebitdantm_ev_sales |
| AVGOBroadcom Inc1.80% weight | Tickerdraft | Confirm that AI semiconductor revenue growth and software cash flow support the premium multiple. | AI semiconductor revenueInfrastructure software growthGross marginFree cash flowGuidance revision | AI semiconductor guide is raisedInfrastructure software integration improves marginsFCF rises and leverage falls | AI demand concentrationIntegration riskHigh valuation | ntm_pefcf_yieldev_ebitda |
| CPNGCoupang Inc1.49% weight | Industrydraft | Confirm that growth and unit economics improve together. | GMV/revenue growthTake rate/ads monetizationOperating marginUsers/ordersGuidance revision | GMV/revenue accelerates with margin expansionAds, logistics, or marketplace monetization improvesConsumer demand weakens or competition rises | Consumer slowdownCompetitionLogistics cost inflation | ntm_ev_salesntm_peebit_margin_path |
| OPCHOption Care Health Inc.1.49% weight | Industrydraft | Track whether utilization, reimbursement, and operating margins support durable earnings growth. | Volume/member growthReimbursement/pricingCost ratio/service costsOperating marginGuidance revision | Volume/member growth acceleratesMargins improve or cost ratio fallsReimbursement or utilization outlook changes | Reimbursement pressurePolicy riskCost inflation | ntm_peev_ebitdarevenue_growth_adjusted_multiple |
| CRHCRH Plc1.18% weight | Sectordraft | Confirm that realized prices, volumes, and margins support a materials-cycle thesis. | Realized priceVolume growthCash costFree cash flowGuidance revision | Commodity price and volume improve togetherCash costs fall or FCF risesManagement raises outlook | Commodity price declineCost inflationDemand slowdown | ev_ebitdafcf_yieldprice_to_book |
| FIGRFigure Technology Solutions In1.16% weight | Sectordraft | Track the macro variables and underlying exposure that explain the ETF or financial vehicle. | Underlying index returnCurrency/rate signalCommodity/country signalFlows/liquidityRelative strength | Underlying market breaks out or rolls overCurrency/rate/commodity backdrop shiftsETF liquidity or flows become stressed | Country riskCurrency riskLiquidity risk | nav_discount_premiumunderlying_perelative_strength |
| ARGTGlobal X MSCI Argentina ETF1.07% weight | Industrydraft | Track the macro variables and underlying exposure that explain the ETF or financial vehicle. | Underlying index returnCurrency/rate signalCommodity/country signalFlows/liquidityRelative strength | Underlying market breaks out or rolls overCurrency/rate/commodity backdrop shiftsETF liquidity or flows become stressed | Country riskCurrency riskLiquidity risk | nav_discount_premiumunderlying_perelative_strength |
| CAICaris Life Sciences Inc.1.00% weight | Industrydraft | Track whether utilization, reimbursement, and operating margins support durable earnings growth. | Volume/member growthReimbursement/pricingCost ratio/service costsOperating marginGuidance revision | Volume/member growth acceleratesMargins improve or cost ratio fallsReimbursement or utilization outlook changes | Reimbursement pressurePolicy riskCost inflation | ntm_peev_ebitdarevenue_growth_adjusted_multiple |
| QSRRestaurant Brands Internationa0.99% weight | Sectordraft | Confirm that demand and margins improve without excessive valuation pressure. | Same-store/revenue growthGross marginOperating marginTraffic/ordersGuidance revision | Revenue and traffic/orders accelerateMargins expandGuidance improves | Consumer slowdownPromotional intensityInput cost pressure | ntm_peev_ebitdantm_ev_sales |
| RVMDRevolution Medicines Inc0.91% weight | Industrydraft | Track whether the key product, pipeline, or platform is being validated by data and commercial execution. | Clinical/platform milestonesRevenue/volume growthGross marginCash runwayGuidance/pipeline update | Clinical data, FDA, or reimbursement update changes probability of successCommercial launch or test volume acceleratesCash burn improves or financing risk falls | Clinical failureRegulatory delayDilution | ev_salescash_runwayrisk_adjusted_pipeline_value |
| LSCCLattice Semiconductor Corp.0.89% weight | Industrydraft | Confirm that demand, margins, and inventory are improving enough to justify continued exposure. | Revenue growthGross marginAI/data-center exposureInventory/backlogGuidance revision | Revenue and gross margin beat with raised outlookAI or data-center demand commentary improvesInventory correction ends or backlog strengthens | Semiconductor cycle rolloverCustomer concentrationInventory correction | ntm_pentm_ev_salesgross_margin_adjusted_growth |
| SNDKSandisk Corp0.72% weight | Industrydraft | Track whether order growth, backlog, and margins confirm a hardware cycle upswing. | Orders/backlogRevenue growthGross marginInventoryGuidance revision | Backlog/orders accelerateAI, optical, networking, or storage demand strengthensGross margin expands | Hardware cycle reversalCustomer concentrationInventory correction | ntm_peev_ebitdantm_ev_sales |
| UALUnited Airlines Holdings Inc0.72% weight | Tickerdraft | Confirm that unit revenue and margins improve enough to offset fuel, labor, and cycle risk. | Unit revenueCapacity growthFuel costOperating marginFCF/debt | Unit revenue and load factor improveFuel or labor cost pressure easesCapacity discipline holds | Fuel spikeRecession/travel slowdownLabor cost inflation | ntm_peev_ebitdafcf_yield |
| HUMHumana Inc0.71% weight | Industrydraft | Track whether utilization, reimbursement, and operating margins support durable earnings growth. | Volume/member growthReimbursement/pricingCost ratio/service costsOperating marginGuidance revision | Volume/member growth acceleratesMargins improve or cost ratio fallsReimbursement or utilization outlook changes | Reimbursement pressurePolicy riskCost inflation | ntm_peev_ebitdarevenue_growth_adjusted_multiple |
| WABWestinghouse Air Brake Technol0.70% weight | Sectordraft | Confirm that backlog, margins, and guidance support continued earnings growth. | Orders/backlogOrganic revenue growthOperating marginBook-to-billGuidance revision | Orders/backlog and margins improveBook-to-bill remains above oneGuidance is raised | Industrial cycle slowdownSupply-chain issuesInput cost pressure | ntm_peev_ebitdafcf_yield |
| TWLOTwilio Inc0.68% weight | Industrydraft | Confirm that growth quality and profitability are improving without excessive valuation pressure. | Revenue growthRetention/usageOperating marginFCF marginGuidance revision | Revenue or usage growth reacceleratesOperating margin or FCF margin expandsAI/product commentary improves demand outlook | Growth decelerationHigh valuationCompetition | ntm_ev_salesrule_of_40fcf_yield |
| JBLJabil Inc0.65% weight | Industrydraft | Track whether order growth, backlog, and margins confirm a hardware cycle upswing. | Orders/backlogRevenue growthGross marginInventoryGuidance revision | Backlog/orders accelerateAI, optical, networking, or storage demand strengthensGross margin expands | Hardware cycle reversalCustomer concentrationInventory correction | ntm_peev_ebitdantm_ev_sales |
| SCCOSouthern Copper Corporation0.62% weight | Sectordraft | Confirm that realized prices, volumes, and margins support a materials-cycle thesis. | Realized priceVolume growthCash costFree cash flowGuidance revision | Commodity price and volume improve togetherCash costs fall or FCF risesManagement raises outlook | Commodity price declineCost inflationDemand slowdown | ev_ebitdafcf_yieldprice_to_book |
| GSGiShares S&P GSCI Commodity-Ind0.61% weight | Industrydraft | Track the macro variables and underlying exposure that explain the ETF or financial vehicle. | Underlying index returnCurrency/rate signalCommodity/country signalFlows/liquidityRelative strength | Underlying market breaks out or rolls overCurrency/rate/commodity backdrop shiftsETF liquidity or flows become stressed | Country riskCurrency riskLiquidity risk | nav_discount_premiumunderlying_perelative_strength |
| LINLinde Plc0.60% weight | Industrydraft | Track whether pricing, volume, and spreads support earnings recovery. | Volume growthPrice-cost spreadEBITDA marginCapacity utilizationGuidance revision | Volume and spreads improve togetherManagement raises EBITDA outlookFeedstock or pricing pressure worsens | Commodity cycle downturnFeedstock inflationDemand weakness | ev_ebitdafcf_yieldmidcycle_ebitda |
| STXSeagate Technology Holdings Pl0.59% weight | Sectordraft | Confirm that growth quality and profitability are improving without excessive valuation pressure. | Revenue growthRetention/usageOperating marginFCF marginGuidance revision | Revenue or usage growth reacceleratesOperating margin or FCF margin expandsAI/product commentary improves demand outlook | Growth decelerationHigh valuationCompetition | ntm_ev_salesrule_of_40fcf_yield |
| CLFCleveland-Cliffs Inc0.58% weight | Sectordraft | Confirm that realized prices, volumes, and margins support a materials-cycle thesis. | Realized priceVolume growthCash costFree cash flowGuidance revision | Commodity price and volume improve togetherCash costs fall or FCF risesManagement raises outlook | Commodity price declineCost inflationDemand slowdown | ev_ebitdafcf_yieldprice_to_book |
| NUVBNuvation Bio Inc0.58% weight | Industrydraft | Track whether the key product, pipeline, or platform is being validated by data and commercial execution. | Clinical/platform milestonesRevenue/volume growthGross marginCash runwayGuidance/pipeline update | Clinical data, FDA, or reimbursement update changes probability of successCommercial launch or test volume acceleratesCash burn improves or financing risk falls | Clinical failureRegulatory delayDilution | ev_salescash_runwayrisk_adjusted_pipeline_value |
| BEBloom Energy Corp0.55% weight | Sectordraft | Confirm that backlog, margins, and guidance support continued earnings growth. | Orders/backlogOrganic revenue growthOperating marginBook-to-billGuidance revision | Orders/backlog and margins improveBook-to-bill remains above oneGuidance is raised | Industrial cycle slowdownSupply-chain issuesInput cost pressure | ntm_peev_ebitdafcf_yield |
| INTCIntel Corp0.54% weight | Industrydraft | Confirm that demand, margins, and inventory are improving enough to justify continued exposure. | Revenue growthGross marginAI/data-center exposureInventory/backlogGuidance revision | Revenue and gross margin beat with raised outlookAI or data-center demand commentary improvesInventory correction ends or backlog strengthens | Semiconductor cycle rolloverCustomer concentrationInventory correction | ntm_pentm_ev_salesgross_margin_adjusted_growth |
| BLTEBelite Bio Inc0.50% weight | Industrydraft | Confirm that product demand and pipeline/regulatory progress offset pricing, patent, and litigation risks. | Product revenue growthPipeline milestonesMargin/cost progressBalance sheetGuidance revision | Product sales beat and guidance is raisedPipeline/regulatory event improves probability of successLitigation, pricing, or patent risk worsens | Patent cliffsPricing pressureRegulatory setbacks | ntm_peev_ebitdafree_cash_flow_yield |
| PTGXProtagonist Therapeutics Inc0.50% weight | Industrydraft | Track whether the key product, pipeline, or platform is being validated by data and commercial execution. | Clinical/platform milestonesRevenue/volume growthGross marginCash runwayGuidance/pipeline update | Clinical data, FDA, or reimbursement update changes probability of successCommercial launch or test volume acceleratesCash burn improves or financing risk falls | Clinical failureRegulatory delayDilution | ev_salescash_runwayrisk_adjusted_pipeline_value |
| UUnity Software Inc0.48% weight | Industrydraft | Confirm that growth quality and profitability are improving without excessive valuation pressure. | Revenue growthRetention/usageOperating marginFCF marginGuidance revision | Revenue or usage growth reacceleratesOperating margin or FCF margin expandsAI/product commentary improves demand outlook | Growth decelerationHigh valuationCompetition | ntm_ev_salesrule_of_40fcf_yield |
| ARMArm Holdings plc0.48% weight | Industrydraft | Confirm that demand, margins, and inventory are improving enough to justify continued exposure. | Revenue growthGross marginAI/data-center exposureInventory/backlogGuidance revision | Revenue and gross margin beat with raised outlookAI or data-center demand commentary improvesInventory correction ends or backlog strengthens | Semiconductor cycle rolloverCustomer concentrationInventory correction | ntm_pentm_ev_salesgross_margin_adjusted_growth |
| OLMAOlema Pharmaceuticals Inc0.44% weight | Industrydraft | Track whether the key product, pipeline, or platform is being validated by data and commercial execution. | Clinical/platform milestonesRevenue/volume growthGross marginCash runwayGuidance/pipeline update | Clinical data, FDA, or reimbursement update changes probability of successCommercial launch or test volume acceleratesCash burn improves or financing risk falls | Clinical failureRegulatory delayDilution | ev_salescash_runwayrisk_adjusted_pipeline_value |
| QQnity Electronics Inc0.43% weight | Industrydraft | Confirm that demand, margins, and inventory are improving enough to justify continued exposure. | Revenue growthGross marginAI/data-center exposureInventory/backlogGuidance revision | Revenue and gross margin beat with raised outlookAI or data-center demand commentary improvesInventory correction ends or backlog strengthens | Semiconductor cycle rolloverCustomer concentrationInventory correction | ntm_pentm_ev_salesgross_margin_adjusted_growth |
| ADMAADMA Biologics Inc0.41% weight | Industrydraft | Track whether the key product, pipeline, or platform is being validated by data and commercial execution. | Clinical/platform milestonesRevenue/volume growthGross marginCash runwayGuidance/pipeline update | Clinical data, FDA, or reimbursement update changes probability of successCommercial launch or test volume acceleratesCash burn improves or financing risk falls | Clinical failureRegulatory delayDilution | ev_salescash_runwayrisk_adjusted_pipeline_value |
| XENEXenon Pharmaceuticals Inc0.41% weight | Industrydraft | Track whether the key product, pipeline, or platform is being validated by data and commercial execution. | Clinical/platform milestonesRevenue/volume growthGross marginCash runwayGuidance/pipeline update | Clinical data, FDA, or reimbursement update changes probability of successCommercial launch or test volume acceleratesCash burn improves or financing risk falls | Clinical failureRegulatory delayDilution | ev_salescash_runwayrisk_adjusted_pipeline_value |
| JBSJBS N.V.0.35% weight | Draftdraft | Identify whether the company's core operating drivers are improving enough to support continued ownership. | Revenue growthMargin trendFree cash flowGuidance revisionValuation pressure | Growth and margin outlook improvesManagement raises guidanceCash flow improves | Growth slowdownMargin pressureHigh valuation | ntm_pentm_ev_salesev_ebitda |
| DAKTDaktronics Inc0.33% weight | Industrydraft | Track whether order growth, backlog, and margins confirm a hardware cycle upswing. | Orders/backlogRevenue growthGross marginInventoryGuidance revision | Backlog/orders accelerateAI, optical, networking, or storage demand strengthensGross margin expands | Hardware cycle reversalCustomer concentrationInventory correction | ntm_peev_ebitdantm_ev_sales |
| NETCloudflare Inc0.32% weight | Industrydraft | Confirm that growth quality and profitability are improving without excessive valuation pressure. | Revenue growthRetention/usageOperating marginFCF marginGuidance revision | Revenue or usage growth reacceleratesOperating margin or FCF margin expandsAI/product commentary improves demand outlook | Growth decelerationHigh valuationCompetition | ntm_ev_salesrule_of_40fcf_yield |
| LYBLyondellBasell Industries NV0.31% weight | Industrydraft | Track whether pricing, volume, and spreads support earnings recovery. | Volume growthPrice-cost spreadEBITDA marginCapacity utilizationGuidance revision | Volume and spreads improve togetherManagement raises EBITDA outlookFeedstock or pricing pressure worsens | Commodity cycle downturnFeedstock inflationDemand weakness | ev_ebitdafcf_yieldmidcycle_ebitda |
| VISTVista Energy S.A.B. de C.V0.30% weight | Industrydraft | Confirm that cash flow and capital allocation stay strong across the commodity cycle. | Oil/gas price realizationProduction growthFree cash flowCapex disciplineBuyback/dividend | Oil/gas price backdrop improvesProduction and FCF beat expectationsBuyback or dividend intensity rises | Oil price declinePolitical/regulatory riskCapex inflation | ev_ebitdafcf_yieldnet_debt_to_ebitda |
| TWSTTwist Bioscience Corp0.29% weight | Industrydraft | Track whether the key product, pipeline, or platform is being validated by data and commercial execution. | Clinical/platform milestonesRevenue/volume growthGross marginCash runwayGuidance/pipeline update | Clinical data, FDA, or reimbursement update changes probability of successCommercial launch or test volume acceleratesCash burn improves or financing risk falls | Clinical failureRegulatory delayDilution | ev_salescash_runwayrisk_adjusted_pipeline_value |
| COHRCoherent Corp0.28% weight | Sectordraft | Confirm that backlog, margins, and guidance support continued earnings growth. | Orders/backlogOrganic revenue growthOperating marginBook-to-billGuidance revision | Orders/backlog and margins improveBook-to-bill remains above oneGuidance is raised | Industrial cycle slowdownSupply-chain issuesInput cost pressure | ntm_peev_ebitdafcf_yield |
| AMZNAmazon.com Inc0.28% weight | Tickerdraft | Confirm that AWS and advertising growth improve while retail margins keep expanding. | AWS revenue growthAWS marginAdvertising growthRetail operating marginAI capex commentary | AWS growth reacceleratesRetail and advertising margins expandAI capex supports future revenue without hurting FCF too much | Cloud competitionAI capex burdenConsumer slowdown | sum_of_partsntm_ev_ebitdafcf_yield |
| CLSCelestica Inc0.28% weight | Industrydraft | Track whether order growth, backlog, and margins confirm a hardware cycle upswing. | Orders/backlogRevenue growthGross marginInventoryGuidance revision | Backlog/orders accelerateAI, optical, networking, or storage demand strengthensGross margin expands | Hardware cycle reversalCustomer concentrationInventory correction | ntm_peev_ebitdantm_ev_sales |
| STUBStubhub Holdings Inc.0.25% weight | Sectordraft | Confirm that backlog, margins, and guidance support continued earnings growth. | Orders/backlogOrganic revenue growthOperating marginBook-to-billGuidance revision | Orders/backlog and margins improveBook-to-bill remains above oneGuidance is raised | Industrial cycle slowdownSupply-chain issuesInput cost pressure | ntm_peev_ebitdafcf_yield |
| DBVTDBV Technologies0.24% weight | Industrydraft | Confirm that product demand and pipeline/regulatory progress offset pricing, patent, and litigation risks. | Product revenue growthPipeline milestonesMargin/cost progressBalance sheetGuidance revision | Product sales beat and guidance is raisedPipeline/regulatory event improves probability of successLitigation, pricing, or patent risk worsens | Patent cliffsPricing pressureRegulatory setbacks | ntm_peev_ebitdafree_cash_flow_yield |
| MUMicron Technology Inc0.23% weight | Tickerdraft | Confirm that HBM demand and memory pricing support a durable earnings upcycle. | HBM revenueDRAM/NAND pricingGross marginInventoryGuidance revision | HBM ramp and memory pricing improveGross margin expands faster than expectedInventory remains disciplined | Memory downcycleOversupplyCapex intensity | price_to_bookmidcycle_peev_ebitda |
| SATSEchoStar Corp0.21% weight | Sectordraft | Confirm that demand and margins improve without excessive valuation pressure. | Same-store/revenue growthGross marginOperating marginTraffic/ordersGuidance revision | Revenue and traffic/orders accelerateMargins expandGuidance improves | Consumer slowdownPromotional intensityInput cost pressure | ntm_peev_ebitdantm_ev_sales |
| ALMAlmonty Industries Inc0.20% weight | Sectordraft | Confirm that realized prices, volumes, and margins support a materials-cycle thesis. | Realized priceVolume growthCash costFree cash flowGuidance revision | Commodity price and volume improve togetherCash costs fall or FCF risesManagement raises outlook | Commodity price declineCost inflationDemand slowdown | ev_ebitdafcf_yieldprice_to_book |
| PCTPureCycle Technologies Inc.0.15% weight | Sectordraft | Confirm that realized prices, volumes, and margins support a materials-cycle thesis. | Realized priceVolume growthCash costFree cash flowGuidance revision | Commodity price and volume improve togetherCash costs fall or FCF risesManagement raises outlook | Commodity price declineCost inflationDemand slowdown | ev_ebitdafcf_yieldprice_to_book |
| LITELumentum Holdings Inc0.14% weight | Industrydraft | Track whether order growth, backlog, and margins confirm a hardware cycle upswing. | Orders/backlogRevenue growthGross marginInventoryGuidance revision | Backlog/orders accelerateAI, optical, networking, or storage demand strengthensGross margin expands | Hardware cycle reversalCustomer concentrationInventory correction | ntm_peev_ebitdantm_ev_sales |
| MELIMercadoLibre Inc0.14% weight | Draftdraft | Identify whether the company's core operating drivers are improving enough to support continued ownership. | Revenue growthMargin trendFree cash flowGuidance revisionValuation pressure | Growth and margin outlook improvesManagement raises guidanceCash flow improves | Growth slowdownMargin pressureHigh valuation | ntm_pentm_ev_salesev_ebitda |
| SOLSSolstice Advanced Materials In0.14% weight | Industrydraft | Track whether pricing, volume, and spreads support earnings recovery. | Volume growthPrice-cost spreadEBITDA marginCapacity utilizationGuidance revision | Volume and spreads improve togetherManagement raises EBITDA outlookFeedstock or pricing pressure worsens | Commodity cycle downturnFeedstock inflationDemand weakness | ev_ebitdafcf_yieldmidcycle_ebitda |
| WLKWestlake Corporation0.07% weight | Industrydraft | Track whether pricing, volume, and spreads support earnings recovery. | Volume growthPrice-cost spreadEBITDA marginCapacity utilizationGuidance revision | Volume and spreads improve togetherManagement raises EBITDA outlookFeedstock or pricing pressure worsens | Commodity cycle downturnFeedstock inflationDemand weakness | ev_ebitdafcf_yieldmidcycle_ebitda |
| WVEWAVE Life Sciences Ltd0.04% weight | Industrydraft | Track whether the key product, pipeline, or platform is being validated by data and commercial execution. | Clinical/platform milestonesRevenue/volume growthGross marginCash runwayGuidance/pipeline update | Clinical data, FDA, or reimbursement update changes probability of successCommercial launch or test volume acceleratesCash burn improves or financing risk falls | Clinical failureRegulatory delayDilution | ev_salescash_runwayrisk_adjusted_pipeline_value |
These draft templates define each stock's operating drivers. They do not yet score recent earnings or news; that signal layer is the next step.